Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 32, Issue 1, 2015, Pages 1-59

  Uskoković, Vuk ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Calcium phosphate; Composites; Controlled drug delivery; Nanoparticle; Osteomyelitis

Indexed keywords

ANTIBIOTIC AGENT; BIODEGRADABLE PLASTIC; BISPHOSPHONIC ACID DERIVATIVE; BONE MORPHOGENETIC PROTEIN; CALCIUM PHOSPHATE; CALCIUM SULFATE; CEFTRIAXONE; COLLAGEN SPONGE; DRUG CARRIER; FIBRIN GLUE; GENTAMICIN; HYDROXYAPATITE; METAL; MOLECULAR SCAFFOLD; NANOMATERIAL; POLYASPARTIC ACID; POLYESTER; POLYGLACTIN; SILICON DERIVATIVE; SILVER; TEICOPLANIN; TITANIUM DIOXIDE NANOPARTICLE; VANCOMYCIN; ZINC OXIDE NANOPARTICLE; ANTIINFECTIVE AGENT; DELAYED RELEASE FORMULATION; NANOPARTICLE;

ARTICLE; BACTERIAL COLONIZATION; BIOFILM; BONE INFECTION; COMPOSITE MATERIAL; CONFOCAL MICROSCOPY; CONTROLLED DRUG RELEASE; DEBRIDEMENT; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; DRUG RELEASE; DRUG SPECIFICITY; GEL; IMMUNOFLUORESCENCE TEST; OSTEOMYELITIS; POROSITY; STAPHYLOCOCCUS AUREUS; VISCOELASTICITY; ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG DESIGN; HUMAN; PROCEDURES;

ANIMALS; ANTI-BACTERIAL AGENTS; DEBRIDEMENT; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; NANOPARTICLES; NANOSTRUCTURES; OSTEOMYELITIS;

EID: 84922741102     PISSN: 07434863     EISSN: 2162660X     Source Type: Journal    
DOI: 10.1615/CritRevTherDrugCarrierSyst.2014010920     Document Type: Article

References (484)

1. Lew DP, Waldvogel FA. Osteomyelitis. Lancet 2004;364(9431):369-79.
2. DeWald RL. Spinal deformities. New York: Thieme Medical Publishers, Inc.; 2003. p. 222.
3. Ikpeme IA, Ngim NE, Ikpeme AA. Diagnosis and treatment of pyogenic bone infections. Afr Health Sci 2010;10(1):82-8.
4. Office of the Surgeon General. Bone health and osteoporosis: a report of the Surgeon General. Rockville: US Department of Health and Human Services; 2004.
5. Paluska SA. Osteomyelitis. Clin Fam Practice 2004;6(1):127-56.
6. King RW, Johnson DL. Osteomyelitis. In: Stearns DA, Talavera F, Weiss EL, Halamka JD, Kulkarni R, editors. eMedicine Medscape Reference, retrieved from http://emedicine.medscape.com/ article/785020-overview#a0101, 2011.
7. Bisland SK, Chien C, Wilson BC, Burch S. Pre-clinical in vitro and in vivo studies to examine the potential use of photodynamic therapy in the treatment of osteomyelitis. Photochem Photobio Sci 2006;5:31-8.
8. Khan AN, Macdonald S. Osteomyelitis, chronic. In: Gentili A, Coombs BD, Beltran J, Krasny RM, Chew FS, editors. eMedicine Medscape Reference, retrieved from http://emedicine.medscape.com/ article/393345-overview, 2011
9. Vanarsdale WW. II. On the present state of knowledge in bacterial science in its surgical relations (continued): osteomyelitis. Ann Surg 1886;3:221-6.
10. Qureshi AT, Terrell L, Monroe WT, Dasa V, Janes ME, Gimble JM, Hayes DJ. Antimicrobial biocompatible bioscaffolds for orthopaedic implants. J Tissue Eng Regen Med 2014;8(5):386-95.
11. Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. N Engl J Med 1970;282:198-206.
12. Del Pozo JL, Patel R. Infection associated with prosthetic joints. N Engl J Med 2009;361:787-94.
13. Blyth CC, Gomes L, Sorrell TC, da Cruz M, Sud A, Chen SC. Skull-base osteomyelitis: fungal vs. bacterial infection. Clin Microbiol Infect 2011;17(2):306-11.
14. Slenker AK, Keith SW, Horn DL. Two hundred and eleven cases of Candida osteomyelitis: 17 case reports and a review of the literature. Diagn Microbiol Infect Dis 2012;73(1):89-93.
15. Dotis J, Roilides E. Osteomyelitis due to Aspergillus species in chronic granulomatous disease: an update of the literature. Mycoses 2011;54(6):e686-9.
16. Fowler TP, Keener J, Buckwalter JA. Brucella osteomyelitis of the proximal tibia: a case report. Iowa Orthop J 2004;24:30-2.
17. Pääkkönen M, Kallio PE, Kallio MJ, Peltola H. Management of osteoarticular infections caused by Staphylococcus aureus is similar to that of other etiologies: analysis of 199 staphylococcal bone and joint infections. Pediatr Infect Dis J 2012;31(5):436-8.
18. Saifudheen K, Anoop TM, Mini PN, Ramachandran M, Jabbar PK, Jayaprakash R. Primary tubercular osteomyelitis of the sternum. Int J Infect Dis 2010;14(2):e164-6.
19. Walsh DS, Portaels F, Meyers WM. Buruli ulcer (Mycobacterium ulcerans infection). Trans R Soc Trop Med Hyg 2008;102(10):969-78.
20. Balaji D. Osteomyelitis variolosa: a case report. J Orthop Surg (Hong Kong) 2011;19:120-2.
21. Lentz MW, Noyes FR. Osseous deformity from osteomyelitis variolosa. A case report. Clin Orthop Relat Res 1979;143:155-7.
22. Al-Jassir FF, Aldeeri RA, Alsiddiky AM, Zamzam MM. Osteomyelitis following Bacille Calmette- Guerin vaccination. Saudi Med J 2012;33(1):87-90.
23. Singhai RK. Osteo-articular complications of smallpox vaccination. J Indian Med Assoc 1970;55: 20-2.
24. Mruk AL, Record KE. Antimicrobial options in the treatment of adult staphylococcal bone and joint infections in an era of drug shortages. Orthopedics 2012;35(5):401-7.
25. Montanaro L, Testoni F, Poggi A, Visai L, Speziale P, Arciola CR. Emerging pathogenetic mechanisms of the implant-related osteomyelitis by Staphylococcus aureus. Int J Artif Organs 2011;34(9):781-8.
26. Conlon HA. Human bites in the classroom: incidence, treatment, and complications. J Sch Nurs 2007;23:197-201.
27. Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: Clinical features, therapeutic considerations, and unusual aspects. Springfield: Charles C. Thomas; 1971.
28. Salgado CJ, Jamali AA, Mardini S. A model for chronic osteomyelitis using Staphylococcus aureus in goats. Clin Orthop Relat Res 2005;436:246-50.
29. Baltensperger, MM, Eyrich GK. Osteomyelitis of the jaws. Berlin: Springer-Verlag; 2009.
30. Krakowiak PA. Alveolar osteitis and osteomyelitis of the jaws. Oral Maxillofac Surg Clin North Am 2011;23(3):401-13.
31. Humber CC, Albilia JB, Rottenberg B. Chronic osteomyelitis following an uncomplicated dental extraction. J Can Dent Assoc 2011;77:b98.
32. Yenson A, de Fries HO, Deeb ZE. Actinomycotic osteomyelitis of the facial bones and mandible. Otolaryngol Head Neck Surg 1983;91(2):173-6.
33. Hatzenbuehler J, Pulling TJ. Diagnosis and management of osteomyelitis. Am Fam Physician 2011;84(9)1027-33.
34. Buchholz HW, Engelbrecht H. Depot effects of various antibiotics mixed with Palacos resins. Chirurg 1970;41:511-15.
35. Dingeldein E, Wahlig H. Gentamycin-konzentration in korperflussigkeit von patienten nach implantation von gentamycin-PMMA-kugeln. In: Contzen H, editor. Unfallchirurgie, Symposium Munchen 1. Erlangen:Verlag, 1976, p. 8.
36. McLaren AC. Alternative materials to acrylic bone cement for delivery of depot antibiotics in orthopaedic infections. Clin Orthop Relat Res 2004;427:101-6.
37. Klemm K. The use of antibiotic-containing bead chains in the treatment of chronic bone infections. Clin Microbiol Infect 2001;7(1):28-31.
38. Alonge TO, Ogunlade SO, Omololu AB, Fashina AN, Oluwatosin A. Management of chronic osteomyelitis in a developing country using ceftriaxone-PMMA beads: an initial study. Int J Clin Pract 2002;56(3):181-3.
39. Giavaresi G, Borsari V, Fini M, Giardino R, Sambri V, Gaibani P, Soffiatti R. Preliminary investigations on a new gentamicin and vancomycin-coated PMMA nail for the treatment of bone and intramedullary infections: An experimental study in the rabbit. J Orthop Res 2008;26(6):785-92.
40. Roeder B, Van Gils CC, Maling S. Antibiotic beads in the treatment of diabetic pedal osteomyelitis. J Foot Ankle Surg 2000;39(2):124-30.
41. Nelson CL, Hickmon SG, Harrison BH. Elution characteristics of gentamicin-PMMA beads after implantation in humans. Orthopedics 1994;17(5):415-6.
42. Moojen DJ, Hentenaar B, Charles Vogely H, Verbout AJ, Castelein RM, Dhert WJ. In vitro release of antibiotics from commercial PMMA beads and articulating hip spacers. J Arthroplasty 2008;23(8):1152-6.
43. Wong MW, Hui M. Development of gentamicin resistance after gentamicin-PMMA beads for treatment of foot osteomyelitis: report of two cases. Foot Ankle Int 2005;26(12):1093-5.
44. Shinsako K, Okui Y, Matsuda Y, Kunimasa J, Otsuka M. Effects of bead size and polymerization in PMMA bone cement on vancomycin release. Biomed Mater Eng 2008;8(6):377-85.
45. Greene N, Holtom PD, Warren CA, Ressler RL, Shepherd L, McPherson EJ, Patzakis MJ. In vitro elution of tobramycin and vancomycin polymethylmethacrylate beads and spacers from Simplex and Palacos. Am J Orthop (Belle Mead NJ) 1998;27(3):201-5.
46. Adams K, Couch L, Cierny G, Calhoun J, Mader JT. In vitro and in vivo evaluation of antibiotic diffusion from antibiotic-impregnated polymethylmethacrylate beads. Clin Orthop Relat Res 1992;278:244-52.
47. Bereznowski Z. In vivo assessment of methyl methacrylate metabolism and toxicity. Int J Biochem Cell Biol 1995;27(12):1311-6.
48. Mainwaring G, Foster JR, Lund V, Green T. Methyl methacrylate toxicity in rat nasal epithelium: studies of the mechanism of action and comparisons between species. Toxicology 2001;158(3):109-18.
49. Anagnostakos K, Hitzler P, Pape D, Kohn D, Kelm J. Persistence of bacterial growth on antibioticloaded beads: Is it actually a problem? Acta Orthopaedica 2008;79:302-7.
50. El-Husseiny M, Patel S, MacFarlane RJ, Haddad FS. Biodegradable antibiotic delivery systems. J Bone Joint Surg Br 2011;93(2):151-7.
51. Gogia JS, Meehan JP, Di Cesare PD, Jamali AA. Local antibiotic therapy in osteomyelitis. Seminar Plastic Surgery 2009;23(2)100-7.
52. Nelson CL, Griffin FM, Harrison BH, Cooper RE. In vitro elution characteristics of commercially and noncommercially prepared antibiotic PMMA beads. Clin Orthop Relat Res 1992;284:303-9.
53. Schnettler R, Steinau HU. Septic bone and joint surgery. Stuttgart:Thieme; 2010.
54. Barth RE, Vogely HC, Hoepelman AI, Peters EJ. 'To bead or not to bead?' Treatment of osteomyelitis and prosthetic joint-associated infections with gentamicin bead chains. Int J Antimicrob Agents 2011;38(5):371-5.
55. Evans RP, Nelson CL. Gentamicin-impregnated polymethylmethacrylate beads compared with systemic antibiotic therapy in the treatment of chronic osteomyelitis. Clin Orthop Relat Res 1993;295: 37-42.
56. Blaha JD, Calhoun JH, Nelson CL, Henry SL, Seligson D, Esterhai JL Jr, Heppenstall RB, Mader J, Evans RP, Wilkins J. Comparison of the clinical efficacy and tolerance of gentamicin PMMA beads on surgical wire versus combined and systemic therapy for osteomyelitis. Clin Orthop Relat Res 1993;295:8-12.
57. Thomas MV, Puleo DA. Calcium sulfate: Properties and clinical applications. J Biomed Mater Res B Appl Biomater 2009;88(2):597-610.
58. Jaeblon T. Polymethylmethacrylate: properties and contemporary uses in orthopaedics. J Am Acad Orthop Surg 2010;18(5):297-305.
59. Kanellakopoulou K, Galanopoulos I, Soranoglou V, Tsaganos T, Tziortzioti V, Maris I, Papalois A, Giamarellou H, Giamarellos-Bourboulis EJ. Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a synthetic carrier of calcium sulphate (Stimulan) releasing moxifloxacin. Int J Antimicrob Agents 2009;33(4):354-9.
60. Jia WT, Luo SH, Zhang CQ, Wang JQ. In vitro and in vivo efficacies of teicoplanin-loaded calcium sulfate for treatment of chronic methicillin-resistant Staphylococcus aureus osteomyelitis. Antimicrob Agents Chemother 2010;54(1):170-6.
61. Dreesmann H. Ueber knochenplombierung. Beitr Klin Chir 1892;9:804-10.
62. Dasmah A, Hallman M, Sennerby L, Rasmusson L. A clinical and histological case series study on calcium sulfate for maxillary sinus floor augmentation and delayed placement of dental implants. Clin Implant Dent Relat Res 2012;14(2):259-65.
63. Andreana S. A combined approach for treatment of developmental groove associated periodontal defect. A case report. J Periodontol 1998;69:601-7.
64. Mittal M, Chandra S, Chandra S. An evaluation of plaster of Paris barriers used under various materials to repair furcation perforations (in vitro study). J Endod 1999;25:385-8.
65. Jepegnanam TS, von Schroeder HP. Rapid resorption of calcium sulfate and hardware failure following corrective radius osteotomy: 2 case reports. J Hand Surg Am 2012;37(3):477-80.
66. Ziran BH, Smith WR, Morgan SJ. Use of calcium-based demineralized bone matrix/allograft for nonunions and posttraumatic reconstruction of the appendicular skeleton: preliminary results and complications. J Trauma 2007;63(6):1324-8.
67. Greish YE, Brown PW. Phase evolution during the formation of stoichiometric hydroxyapatite at 37.4 degrees C. J Biomed Mater Res B Appl Biomater 2003;67:632-7.
68. Combes C, Miao B, Bareille R, Rey C. Preparation, physical-chemical characterisation and cytocompatibility of calcium carbonate cements. Biomaterials 2006;27(9):1945-54.
69. Kurkcu M, Benlidayi ME, Cam B, Sertdemir Y. Anorganic bovine-derived hydroxyapatite vs β-tricalcium phosphate in sinus augmentation: a comparative histomorphometric study. J Oral Implantol 2012;38 Spec No:519-26.
70. Ikenaga M, Hardouin P, Lemaitre J, Andrianjatovo H, Flautre B. Biomechanical characterization of a biodegradable calcium phosphate hydraulic cement: a comparison with porous biphasic calcium phosphate ceramics. J Biomed Mater Res 1998;40:139-44.
71. Kuemmerle JM, Oberle A, Oechslin C, Bohner M, Frei C, Boecken I, von Rechenberg B. Assessment of the suitability of a new brushite calcium phosphate cement for cranioplasty - an experimental study in sheep. J Craniomaxillofac Surg 2005;33(1):37-44.
72. Heybeli N, Oktar FN, Ozyazgan S, Akkan G, Ozsoy S. Low-cost antibiotic loaded systems for developing countries. Technol Health Care 2003;11(3):207-16.
73. McKee MD, Li-Bland EA, Wild LM, Schemitsch EH. A prospective, randomized clinical trial comparing an antibiotic-impregnated bioabsorbable bone substitute with standard antibiotic-impregnated cement beads in the treatment of chronic osteomyelitis and infected nonunion. J Orthop Trauma 2010;24(8):483-90.
74. Beuerlein MJ, McKee MD. Calcium sulfates: what is the evidence? J Orthop Trauma 2010;24 Suppl 1:S46-51.
75. de Klaver PA, Hendriks JG, van Onzenoort HA, Schreurs BW, Touw DJ, Derijks LJ. Gentamicin serum concentrations in patients with gentamicin-PMMA beads for infected hip joints: a prospective observational cohort study. Ther Drug Monit 2012;34(1):67-71.
76. Melamed EA, Peled E. Antibiotic impregnated cement spacer for salvage of diabetic osteomyelitis. Foot Ankle Int 2012;33(3):213-9.
77. Fargues PC, Bailly M, Grevillot G. Adsorption of BSA and hemoglobin on hydroxyapatite support: equilibria and multicomponent dynamic adsorption. Adsorption - J Int Adsorption Soc 1998;4(1):5-16.
78. Gagnon P. Improved antibody aggregate removal by hydroxyapatite chromatography in the presence of polyethylene glycol. J Immun Meth 2008;336(2):222-8.
79. Jungbauer A, Hahn R, Deinhofer K, Luo P. Performance and characterization of a nanophased porous hydroxyapatite for proten chromatography. Biotechnol Bioeng 2004;87:364-75.
80. Giovannini R, Freitag R. Comparison of different types of ceramic hydroxyapatite for the chromatographic separation of plasmid DNA and a recombinant anti-Rhesus D antibody. Bioseparation 2001;9:359-68.
81. Yu S, Geng J, Zhou P, Wang J, Chen X, Hu J. New hydroxyapatite monolithic column for DNA extraction and its application in the purification of Bacillus subtilis crude lysate. J Chromatography A 2008;1183:29-37.
82. Gagnon P, Ng P, Zhen J, Aberin C, He J, Mekosh H, Cummings L, Zaidi S, Richieri R. A ceramic hydroxyapatite-based purification platform. Simultaneous removal of leached Protein A, aggregates, DNA, and endotoxins from MABs. BioProcess Int 2006;4:50-60.
83. Saito M, Kurosawa Y, Okuyama T. Scanning electron microscopy-based approach to understand the mechanism underlying the adhesion of dengue viruses on ceramic hydroxyapatite columns. PLoS One 2013;8(1):e53893.
84. Hilbrig F, Freitag R. Hydroxyapatite in bioprocessing. In: Subramanian G, editor. Biopharmaceutical production technology, Volume 1. Weinheim: Wiley-VCH; 2012, p. 283 - 331.
85. Kawasaki T, Niikura M, Kobayashi Y. Fundamental study of hydroxyapatite high-performance liquid chromatography: II. Experimental analysis on the basis of the general theory of gradient chromatography. J Chromatography 1990;515:91-123.
86. Midy V, Rey C, Bres E, Dard M. Basic fibroblast growth factor adsorption and release properties of calcium phosphate. J Biomed Mater Res 1998;41(3):405-11.
87. Zhu XD, Zhang HJ, Fan HS, Li W, Zhang XD. Effect of phase composition and microstructure of calcium phosphate ceramic particles on protein adsorption. Acta Biomater 2010;6(4):1536-41.
88. Chen YL, Zhang XF, Gong YD, Zhao NM, Zeng TY, Song XQ. Conformational changes of fibrinogen adsorption onto hydroxyapatite and titanium oxide nanoparticles. J Colloid Interface Sci 1999;214(1):38-45.
89. Fujii S, Okada M, Sawa H, Furuzono T, Nakamura Y. Hydroxyapatite nanoparticles as particulate emulsifier: fabrication of hydroxyapatite-coated biodegradable microspheres. Langmuir 2009;25(17):9759-66.
90. Uskoković V, Desai TA. Phase composition control of calcium phosphate nanoparticles for tunable drug delivery kinetics and treatment of osteomyelitis. Part 1: Preparation and drug release. J Biomed Mat Res A 2013;101:1416-26.
91. Uskoković V, Uskoković DP. Nanosized hydroxyapatite and other calcium phosphates: Chemistry of formation and application as drug and gene delivery agents. J Biomed Mat Res B Appl Biomat 2011;96B(1):152-91.
92. Ignjatović NL, Ajduković ZR, Savić VP, Uskoković DP. Size effect of calcium phosphate coated with poly-DL-lactide- co-glycolide on healing processes in bone reconstruction. J Biomed Mat Res B Appl Biomat 2010;94B:108-17.
93. Boskey AL, Myers ER. Is bone mineral crystal size a significant contributor to "bone quality"? IBMS BoneKEy-Osteovision 2004;1:4-7.
94. Eppell SJ, Tong W, Katz JL, Kuhn L, Glimcher MJ. Shape and size of isolated bone mineralites measured using atomic force microscopy. J Orthop Res 2001;19:1027-34.
95. Ishikawa K, Asaoka K. Estimation of ideal mechanical strength and critical porosity of calcium phosphate cement. J Biomed Mater Res 1995;29:1537-43.
96. Linhart W, Briem D, Amling M, Rueger JM, Windolf J. Mechanical failure of porous hydroxyapatite ceramics 7.5 years after implantation in the proximal tibial. Unfallchirurg 2004;107(2):154-7.
97. Hofmann MP, Mohammed AR, Perrie Y, Gbureck U, Barralet JE. High-strength resorbable brushite bone cement with controlled drug-releasing capabilities. Acta Biomater 2009;5:43-9.
98. Bohner M, Baumgart F. Theoretical model to determine the effects of geometrical factors on the resorption of calcium phosphate bone substitutes. Biomaterials 2004;25(17):3569-82.
99. Liu C, Shen W, Chen J. Solution property of calcium phosphate cement hardening body. Mat Chem Phys 1999;58:78-82.
100. Takagi S, Frukhtbeyn S, Chow LC, Sugawara A, Fujikawa K, Ogata H, Hayashi M, Ogiso B. In vitro and in vivo characteristics of fluorapatite-forming calcium phosphate cements. J Res Natl Inst Stand Technol 2010;115(4):267-76.
101. Bohner, M, Brunner TJ, Stark WJ. Controlling the reactivity of calcium phosphate cements. J Mater Chem 2008;18:5669-75.
102. Ambard AJ, Mueninghoff L. Calcium phosphate cement: review of mechanical and biological properties. J Prosthodont 2006;15:321-8.
103. Dorozhkin SV. Calcium orthophosphates in nature, biology and medicine. Materials 2009;2(2): 399-498.
104. Combes C, Rey C. Amorphous calcium phosphates: synthesis, properties and uses in biomaterials. Acta Biomat 2010;6:3362-78.
105. Magalhaes MCF, Marques PAAP, Correia RN. Calcium and magnesium phosphates: normal and pathological mineralization. In: Königsberger E, Königsberger LC, editors. Biomineralization - medical aspects of solubility. Chichester: John Wiley & Sons; 2006, p. 71-124.
106. Webb NC. The crystal structure of β-Ca2P2O7. Acta Cryst 1966;21:942-8.
107. Bennett RM, Lehr JR, McCarty DJ. Factors affecting the solubility of calcium pyrophosphate dihydrate crystals. J Clin Invest 1975;56(6):1571-9.
108. Dorozhkin S. Self-setting calcium orthophosphate formulations. J Funct Biomat 2013;4:209-311.
109. Confavreux CB. Bone: from a reservoir of minerals to a regulator of energy metabolism. Kidney Int Suppl 2011;121:S14-9.
110. Park EK, Lee YE, Choi JY, Oh SH, Shin HI, Kim KH, Kim SY, Kim S. Cellular biocompatibility and stimulatory effects of calcium metaphosphate on osteoblastic differentiation of human bone marrowderived stromal cells. Biomaterials 2004;25:3403-11.
111. Liu YK, Lu QZ, Pei R, Ji HJ, Zhou GS, Zhao XL, Tang RK, Zhang M. The effect of extracellular calcium and inorganic phosphate on the growth and osteogenic differentiation of mesenchymal stem cells in vitro: implication for bone tissue engineering. Biomed Mater 2009;4(2):025004.
112. Mailland M, Waelchli R, Ruat M, Boddeke HG, Seuwen K. Stimulation of cell proliferation by calcium and a calcimimetic compound. Endocrinology 1997;138:3601-5.
113. Rainer A, Centola M, Spadaccio C, Gherardi G, Genovese JA, Licoccia S, Trombetta M. Comparative study of different techniques for the sterilization of poly-L-lactide electrospun microfibers: effectiveness vs. material degradation. Int J Artif Organs 2010;33(2):76-85.
114. Báez LA, Langston C, Givaruangsawat S, McLaughlin R. Evaluation of in vitro serial antibiotic elution from meropenem-impregnated polymethylmethacrylate beads after ethylene oxide gas and autoclave sterilization. Vet Comp Orthop Traumatol 2011;24(1):39-44.
115. França R, Mbeh DA, Samani TD, Le Tien C, Mateescu MA, Yahia L, Sacher E. The effect of ethylene oxide sterilization on the surface chemistry and in vitro cytotoxicity of several kinds of chitosan. J Biomed Mater Res B Appl Biomater 2013;101(8):1444-55.
116. Cottam E, Hukins DWL, Lee K, Hewitt C, Jenkins MJ. Effect of sterilisation by gamma irradiation on the ability of polycaprolactone (PCL) to act as a scaffold material. Med Eng Phys 2009;31:221-6.
117. Wang P, Li C, Gong H, Jiang X, Wang H, Li K. Effects of synthesis conditions on the morphology of hydroxyapatite nanoparticles produced by wet chemical process. Powder Tech 2010;203:315-21.
118. Grandjean-Laquerriere A, Laquerriere P, Guenounou M, Laurent-Maquin D, Phillips TM. Importance of the surface area ratio on cytokines production by human monocytes in vitro induced by various hydroxyapatite particles. Biomaterials 2005;26(15):2361-9.
119. Xu Z, Liu C, Wei J, Sun J. Effects of four types of hydroxyapatite nanoparticles with different nanocrystal morphologies and sizes on apoptosis in rat osteoblasts. J Appl Toxicol 2012;32(6):429-35.
120. Huang LCL, Chang HC. Adsorption and immobilization of cytochrome c on nanodiamonds. Langmuir 2004;20(14):5879-84.
121. Uskoković V, Batarni SS, Schweicher J, King A, Desai TA. The effect of morphology of calcium phosphate nanoparticles for sustained release of antibiotics on their antibacterial and osteogenic performance. ACS Appl Mat Interfaces 2013;5(7):2422-31.
122. Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R. Enhanced functions of osteoblasts on nanophase ceramics. Biomaterials 2000;21(17):1803-10.
123. Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R. Enhanced osteoclast-like cell functions on nanophase ceramics. Biomaterials 2001;22(11):1327-33.
124. Ziv V, Weiner S. Bone crystal sizes: A comparison of transmission electron microscopic and X-ray diffraction line width broadening techniques. Connect Tissue Res 1993;29:1-11.
125. Singh N, Manshian B, Jenkins GJS, Griffiths SM, Williams PM, Maffeis TGG, Wright CJ, Doak SH. Nanogenotoxicology: the DNA damaging potential of engineered nanomaterials. Biomaterials 2009;30:3891-914.
126. Itokazu M, Yang W, Aoki T, Ohara A, Kato N. Synthesis of antibiotic-loaded interporous hydroxyapatite blocks by vacuum method and in vitro drug release testing. Biomaterials 1998;19(7-9):817-9.
127. Petrone C, Hall G, Langman M, Filiaggi MJ. Compaction strategies for modifying the drug delivery capabilities of gelled calcium polyphosphate matrices. Acta Biomater 2008;4(2):403-13.
128. Rauschmann MA, Wichelhaus TA, Stirnal V, Dingeldein E, Zichner L, Schnettler R, Alt V. Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. Biomaterials 2005;26(15):2677-84.
129. Rouahi M, Champion E, Gallet O, Jada A, Anselme K. Physico-chemical characteristics and protein adsorption potential of hydroxyapatite particles: Influence on in vitro biocompatibility of ceramics after sintering. Coll Surf B: Biointerfaces 2006;47(1):10-9.
130. Kim HM, Himeno T, Kokubo T, Nakamura T. Process and kinetics of bonelike apatite formation on sintered hydroxyapatite in a simulated body fluid. Biomaterials 2005;26(21):4366-73.
131. Vukomanović M, Škapin S, Jančar B, Maksin T, Ignjatović N, Uskoković V, Uskoković D. Poly(D,Llactide- co-glycolide)/hydroxyapatite core-shell nanospheres. Part 1: A multifunctional system for controlled drug delivery. Coll Surf B: Biointerfaces 2011;82(2):404-13.
132. Calvente JJ, López-Pérez G, Jurado JM, Andreu R, Molero M, Roldán E. Reorientation of thiols during 2D self-assembly: interplay between steric and energetic factors. Langmuir 2010;26(4):2914-23.
133. Lu X, Jin T, Jin Y, Wu L, Hu B, Tian Y, Fan X. Toxicogenomic analysis of the particle dose- and sizeresponse relationship of silica particles-induced toxicity in mice. Nanotechnology 2013;24(1):015106.
134. Downs TR, Crosby ME, Hu T, Kumar S, Sullivan A, Sarlo K, Reeder B, Lynch M, Wagner M, Mills T, Pfuhler S. Silica nanoparticles administered at the maximum tolerated dose induce genotoxic effects through an inflammatory reaction while gold nanoparticles do not. Mutat Res 2012;14;745(1-2): 38-50.
135. Yazdi AS, Guarda G, Riteau N, Drexler SK, Tardivel A, Couillin I, Tschopp J. Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β. Proc Natl Acad Sci U S A 2010;107(45):19449-54.
136. Bohner M. Designing ceramics for injectable bone graft substitutes. In: Vernon B, editor. Injectable biomaterials: science and applications. Cambridge: Woodhead Publishing; 2011, p. 24 - 45.
137. Neuendorf RE, Saiz E, Tomsia AP, Ritchie RO. Adhesion between biodegradable polymers and hydroxyapatite: Relevance to synthetic bone-like materials and tissue engineering scaffolds. Acta Biomater 2008;4(5):1288-96.
138. Okada M, Furuzono T. Hydroxylapatite nanoparticles: fabrication methods and medical applications. Sci Technol Adv Mater 2012;13:06413.
139. Jiang JL, Li YF, Fang TL, Zhou J, Li XL, Wang YC, Dong J. Vancomycin-loaded nano-hydroxyapatite pellets to treat MRSA-induced chronic osteomyelitis with bone defect in rabbits. Inflamm Res 2012;61(3):207-15.
140. Joosten U, Joist A, Gosheger G, Liljenqvist U, Brandt B, von Eiff C. Effectiveness of hydroxyapatitevancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis. Biomaterials 2005;26(25):5251-8.
141. Nayak AK, Laha B, Sen KK. Development of hydroxyapatite-ciprofloxacin bone-implants using "Quality by design". Acta Pharm 2011;61(1):25-36.
142. Hamanishi C, Kitamoto K, Tanaka S, Otsuka M, Doi Y, Kitahashi T. A self-setting TTCP-DCPD apatite cement for release of vancomycin. J Biomed Mater Res 1996;33(3):139-43.
143. Itokazu M, Matsunaga T, Kumazawa S, Oka M. Treatment of osteomyelitis by antibiotic impregnated porous hydroxyapatite block. Clin Mater 1994;17(4):173-9.
144. Tan Y, Wang G, Fan H, Wang X, Lu J, Zhang X. Expression of core binding factor 1 and osteoblastic markers in C2C12 cells induced by calcium phosphate ceramics in vitro. J Biomed Mater Res A 2007;82(1):152-9.
145. Rupani A, Hidalgo-Bastida LA, Rutten F, Dent A, Turner I, Cartmell S. Osteoblast activity on carbonated hydroxyapatite. J Biomed Mater Res A 2012;100(4):1089-96.
146. Song JH, Kim JH, Park S, Kang W, Kim HW, Kim HE, Jang JH. Signaling responses of osteoblast cells to hydroxyapatite: the activation of ERK and SOX9. J Bone Miner Metab 2008;26(2):138-42.
147. Zhang W, Tsurushima H, Oyane A, Yazaki Y, Sogo Y, Ito A, Matsumura A. BMP-2 gene-fibronectinapatite composite layer enhances bone formation. J Biomed Sci 2011;18:62.
148. Bae SE, Choi J, Joung YK, Park K, Han DK. Controlled release of bone morphogenetic protein (BMP)-2 from nanocomplex incorporated on hydroxyapatite-formed titanium surface. J Control Release 2012;160(3):676-84.
149. Lock J, Liu H. Nanomaterials enhance osteogenic differentiation of human mesenchymal stem cells similar to a short peptide of BMP-7. Int J Nanomedicine 2011;6:2769-77.
150. Matsushita N, Terai H, Okada T, Nozaki K, Inoue H, Miyamoto S, Takaoka K. A new bone-inducing biodegradable porous beta-tricalcium phosphate. J Biomed Mater Res A 2004;70:450-8.
151. Matsushita N, Terai H, Okada T, Nozaki K, Inoue H, Miyamoto S, Takaoka K. Accelerated repair of a bone defect with a synthetic biodegradable bone-inducing implant. J Orthop Sci 2006;11:505-11.
152. Suto M, Nemoto E, Kanaya S, Suzuki R, Tsuchiya M, Shimauchi H. Nanohydroxyapatite increases BMP-2 expression via a p38 MAP kinase dependent pathway in periodontal ligament cells. Arch Oral Biol 2013;58(8):1021-8.
153. Dalby MJ, Gadegaard N, Tare R, Andar A, Riehle MO, Herzyk P, Wilkinson CDW, Oreffo ROC. The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder. Nature Materials 2007;6:997-1003.
154. Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 2011;11(6):471-91.
155. Carragee EJ, Mitsunaga KA, Hurwitz EL, Scuderi GJ. Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study. Spine J 2011;11(6):511-6.
156. Woo EJ. Adverse events after recombinant human BMP2 in nonspinal orthopaedic procedures. Clin Orthop Relat Res 2013;471(5):1707-11.
157. Majid K, Tseng MD, Baker KC, Reyes-Trocchia A, Herkowitz HN. Biomimetic calcium phosphate coatings as bone morphogenetic protein delivery systems in spinal fusion. Spine J 2011;11(6): 560-7.
158. Hu YY, Rawal A, Schmidt-Rohr K. Strongly bound citrate stabilizes the apatite nanocrystals in bone. Proc Natl Acad Sci U S A 2010;107(52):22425-9.
159. Costello LC, Franklin RB, Reynolds MA, Chellaiah M. The important role of osteoblasts and citrate production in bone formation: "osteoblast citration" as a new concept for an old relationship. Open Bone J 2012;4:10.2174/1876525401204010027.
160. Gyawali D, Nair P, Kim HKW, Yang J. Citrate-based biodegradable injectable hydrogel composites for orthopedic applications. Biomat Sci 2013;1:52-64.
161. Tencer AF, Woodard PL, Swenson J, Brown KL. Mechanical and bone ingrowth properties of a polymer-coated, porous, synthetic, coralline hydroxyapatite bone-graft material. Ann N Y Acad Sci 1988;523:157-72.
162. Porter AE, Buckland T, Hing K, Best SM, Bonfield W. The structure of the bond between bone and porous silicon-substituted hydroxyapatite bioceramic implants. J Biomed Mater Res A 2006;78(1): 25-33.
163. del Valle S, Mino N, Munoz F, Gonzalez A, Planell JA, Ginebra MP. In vivo evaluation of an injectable macroporous calcium phosphate cement. J Mater Sci - Mater Med 2007;18:353-61.
164. Takagi S, Chow LC. Formation of macropores in calcium phosphate cement implants. J Mater Sci - Mater Med 2001;12:3395-404.
165. Wepener I, Richter W, van Papendorp D, Joubert AM. In vitro osteoclast-like and osteoblast cells' response to electrospun calcium phosphate biphasic candidate scaffolds for bone tissue engineering. J Mater Sci: Mater Med 2012;23:3029-40.
166. Paris O, Fritz-Popovski G, Van Opdenbosch D, Zollfrank C. Recent progress in the replication of hierarchical biological tissues. Adv Funct Mat 2013;23:4408-22.
167. Marković M, Takagi S, Chow LC. Formation of macropores in calcium phosphate cements through the use of mannitol crystals. Key Eng Mater 2001;192-195:773-6.
168. Xu HHK, Weir MD, Burguera EF, Fraser AM. Injectable and macroporous calcium phosphate cement scaffold. Biomaterials 2006;27:4279-87.
169. Fullana SG, Ternet H, Freche M, Lacout JL, Rodriguez F. Controlled release properties and final macroporosity of a pectin microspheres-calcium phosphate composite bone cement. Acta Biomater 2010;6:2294-300.
170. Almirall A, Larrecq G, Delgado JA, Martínez S, Planell JA, Ginebra MP. Fabrication of low temperature macroporous hydroxyapatite scaffolds by foaming and hydrolysis of an α-TCP paste. Biomaterials 2004;25:3671-80.
171. Tas AC. Preparation of porous apatite granules from calcium phosphate cement. J Mater Sci Mater Med 2008;19:2231-9.
172. Sarda S, Nilsson M, Balcells M, Fernández E. Influence of surfactant molecules as air-entraining agent for bone cement macroporosity. J Biomed Mater Res A 2003;65A:215-21.
173. Wang XP, Ye JD, Li X, Dong H. Production of in-situ macropores in an injectable calcium phosphate cement by introduction of cetyltrimethyl ammonium bromide. J Mater Sci Mater Med 2008;19:3221-5.
174. Lopez-Heredia MA, Sariibrahimoglu K, Yang W, Bohner M, Yamashita D, Kunstar A, van Apeldoorn AA, Bronkhorst EM, Lanao RPF, Leeuwenburgh SCG, Itatani K, Yang F, Salmon P, Wolke JGC, Jansen JA. Influence of the pore generator on the evolution of the mechanical properties and the porosity and interconnectivity of a calcium phosphate cement. Acta Biomater 2012;8:404-14.
175. Lanao RPF, Leeuwenburgh SC, Wolke JG, Jansen JA. In vitro degradation rate of apatitic calcium phosphate cement with incorporated PLGA microspheres. Acta Biomater 2011;7:3459-68.
176. Bohner M. Calcium phosphate emulsions: possible applications. Key Eng Mater 2011;192-195:765-8.
177. Pathi SP, Lin DDW, Dorvee JR, Estroff LA, Fischbach-Teschl C. Hydroxyapatite Nanoparticle-containing scaffolds for study of breast cancer bone metastasis. Biomaterials 2011;32:5112-22.
178. Sionkowska A, Kozłowska J. Properties and modification of porous 3-D collagen/hydroxyapatite composites. Int J Biol Macromol 2013;52:250-9.
179. van der Zande M, Walboomers XF, Brännvall M, Olalde B, Jurado MJ, Alava JI, Jansen JA. Genetic profiling of osteoblast-like cells cultured on a novel bone reconstructive material, consisting of poly-L-lactide, carbon nanotubes and microhydroxyapatite, in the presence of bone morphogenetic protein-2. Acta Biomater 2010;6(11):4352-60.
180. Liao H, Walboomers XF, Habraken WJ, Zhang Z, Li Y, Grijpma DW, Mikos AG, Wolke JG, Jansen JA. Injectable calcium phosphate cement with PLGA, gelatin and PTMC microspheres in a rabbit femoral defect. Acta Biomater 2011;7(4):1752-9.
181. Okazaki M, Sato M, Takahashi J. Space-cutting model of hydroxyapatite. Biomaterials 1995;16(1): 45-9.
182. Gibson IR, Best SM, Bonfield W. Chemical characterization of silicon-substituted hydroxyapatite. J Biomed Mater Res 1999;44(4):422-8.
183. Yao F, LeGeros JP, LeGeros RZ. Simultaneous incorporation of carbonate and fluoride in synthetic apatites: Effect on crystallographic and physico-chemical properties. Acta Biomater 2009;5(6):2169-77.
184. Wopenka B, Pasteris JD. A mineralogical perspective on the apatite in bone. Mat Sci Eng C 2005;25:131-43.
185. Young RA. Biological apatite vs. hydroxyapatite at the atomic level. Clin Orthop Relat Res 1975;113:249-62.
186. Knabe C, Houshmand A, Berger G, Ducheyne P, Gildenhaar R, Kranz I, Stiller M. Effect of rapidly resorbable bone substitute materials on the temporal expression of the osteoblastic phenotype in vitro. J Biomed Mater Res A 2008;15;84(4):856-68.
187. Mann S. Biomineralization. Oxford: Oxford University Press; 2001, p. 50.
188. Okazaki M, LeGeros RZ. Properties of heterogeneous apatites containing magnesium, fluoride, and carbonate. Adv Dent Res 1996;10(2):252-9.
189. Abrams SA, Chen Z, Hawthorne KM. Magnesium metabolism in 4 to 8 year old children. J Bone Miner Res 2013;29(1):118-22.
190. Landi E, Logroscino G, Proietti L, Tampieri A, Sandri M, Sprio S. Biomimetic Mg-substituted hydroxyapatite: from synthesis to in vivo behavior. J Mater Sci Mater Med 2008;19(1):239-47.
191. Roy M, Bose S. Osteoclastogenesis and osteoclastic resorption of tricalcium phosphate: effect of strontium and magnesium doping. J Biomed Mater Res A 2012;100(9):2450-61.
192. Odabasi E, Turan M, Aydin A, Kutlu M. Magnesium, zinc, copper, manganese, and selenium levels in postmenopausal women with osteoporosis. Can magnesium play a key role in osteoporosis? Ann Acad Med Singapore 2008;37:564-7.
193. Aaseth J, Boivin G, Andersen O. Osteoporosis and trace elements - an overview. J Trace Elem Med Biol 2012;26(2-3):149-52.
194. Peng Y, Shi K, Wang L, Lu J, Li H, Pan S, Ma C. Characterization of Osterix protein stability and physiological role in osteoblast differentiation. PLoS One 2013;8(2):e56451.
195. Brown ED, Chan W, Smith Jr. JC. Bone mineralization during a developing zinc deficiency. Proc Soc Exp Biol Med 1978;157:211-4.
196. Thian ES, Konishi T, Kawanobe Y, Lim PN, Choong C, Ho B, Aizawa M. Zinc-substituted hydroxyapatite: a biomaterial with enhanced bioactivity and antibacterial properties. J Mater Sci Mater Med 2013;24(2):437-45.
197. Rodríguez-Valencia C, López-Álvarez M, Cochón-Cores B, Pereiro I, Serra J, González P. Novel selenium-doped hydroxyapatite coatings for biomedical applications. J Biomed Mater Res A 2013;101(3):853-61.
198. Carlisle EM. Proceedings: Silicon as an essential element. Fed Proc 1974;33(6):1758-66.
199. Porter AE, Botelho CM, Lopes MA, Santos JD, Best SM, Bonfield W. Ultrastructural comparison of dissolution and apatite precipitation on hydroxyapatite and silicon-substituted hydroxyapatite in vitro and in vivo. J Biomed Mater Res A 2004;69(4):670-9.
200. Li Y, Li Q, Zhu S, Luo E, Li J, Feng G, Liao Y, Hu J. The effect of strontium-substituted hydroxyapatite coating on implant fixation in ovariectomized rats. Biomaterials 2010;31(34):9006-14.
201. Lin K, Xia L, Li H, Jiang X, Pan H, Xu Y, Lu WW, Zhang Z, Chang J. Enhanced osteoporotic bone regeneration by strontium-substituted calcium silicate bioactive ceramics. Biomaterials 2013;34(38):1028-42.
202. Fielding G, Bose S. SiO2 and ZnO dopants in three-dimensionally printed tricalcium phosphate bone tissue engineering scaffolds enhance osteogenesis and angiogenesis in vivo. Acta Biomater 2013;9(11):9137-48.
203. Saidak Z, Marie PJ. Strontium signaling: molecular mechanisms and therapeutic implications in osteoporosis. Pharmacol Ther 2012;136(2):216-26.
204. Hayakawa S, Kanaya T, Tsuru K, Shirosaki Y, Osaka A, Fujii E, Kawabata K, Gasqueres G, Bonhomme C, Babonneau F, Jäger C, Kleebe HJ. Heterogeneous structure and in vitro degradation behavior of wet-chemically derived nanocrystalline silicon-containing hydroxyapatite particles. Acta Biomater 2013;9(1):4856-67.
205. Pan HB, Li ZY, Lam WM, Wong JC, Darvell BW, Luk KD, Lu WW. Solubility of strontium-substituted apatite by solid titration. Acta Biomater 2009;5(5):1678-85.
206. Barrio DA, Cattaneo ER, Apezteguia MC, Etcheverry SB. Vanadyl(IV) complexes with saccharides. Bioactivity in osteoblast-like cells in culture. Can J Physiol Pharmacol 2006;84: 765-75.
207. Pizzala H, Caldarelli S, Eon JG, Rossi AM, San Gil RA, Laurencin D, Smith ME. A solid-state NMR study of lead and vanadium substitution into hydroxyapatite. J Am Chem Soc 2009;131(14): 5145-52.
208. Hodson ME, Valsami-Jones E, Cotter-Howells JD. Bonemeal additions as a remediation treatment for metal contaminated soil. Environ Sci Technol 2000;34:3501-7.
209. Yang PP, Quan ZW, Li CX, Kang XJ, Lian HZ, Lin J. Bioactive, luminescent and mesoporous europium- doped hydroxyapatite as a drug carrier. Biomaterials 2008;29(32):4341-7.
210. Graeve OA, Kanakala R, Madadi A, Williams BC, Glass KC. Luminescence variations in hydroxyapatites doped with Eu2+ and Eu3+ ions. Biomaterials 2010;31:4259-67.
211. Albernaz MD, Ospina CA, Rossi AM, Santos-Oliveira R. Radiolabelled nanohydroxyapatite with 99mTc: perspectives to nanoradiopharmaceuticals construction. Artif Cells Nanomed Biotechnol 2014;42(2):88-91.
212. Sun J, Xie G. Tissue distribution of intravenously administrated hydroxyapatite nanoparticles labeled with 125I. J Nanosci Nanotechnol 2011;11(12):10996-1000.
213. Thomas S, Mendes JD, Souza SA, Lorenzato CS, Assi PE, Pacheco LR, Gabriel MB, Bordim A, Gutfilen B, da Fonseca LM. Radioactive synovectomy with (90) yttrium and (153) samarium hydroxyapatite in haemophilic joints: preliminary study on radiation safety. Haemophilia 2013;19(4):632-6.
214. Ignjatović N, Ajduković Z, Savić V, Najman S, Mihailović D, Vasiljević P, Stojanović Z, Uskoković V, Uskoković D. Nanoparticles of cobalt-substituted hydroxyapatite in regeneration of mandibular osteoporotic bones. J Mat Sci: Mat Med 2013;24(2):343-54.
215. Gloria A, Russo T, D'Amora U, Zeppetelli S, D'Alessandro T, Sandri M, Bañobre-López M, Piñeiro- Redondo Y, Uhlarz M, Tampieri A, Rivas J, Herrmannsdörfer T, Dediu VA, Ambrosio L, De Santis R. Magnetic poly(ε-caprolactone)/iron-doped hydroxyapatite nanocomposite substrates for advanced bone tissue engineering. J R Soc Interface 2013;10(80):20120833.
216. Panseri S, Cunha C, D'Alessandro T, Sandri M, Giavaresi G, Marcacci M, Hung CT, Tampieri A. Intrinsically superparamagnetic Fe-hydroxyapatite nanoparticles positively influence osteoblast-like cell behavior. J Nanobiotechnology 2012;10:32.
217. Chandra VS, Baskar G, Suganthi RV, Elayaraja K, Joshy MI, Beaula WS, Mythili R, Venkatraman G, Kalkura SN. Blood compatibility of iron-doped nanosize hydroxyapatite and its drug release. ACS Appl Mater Interfaces 2012;4(3):1200-10.
218. Canullo L, Heinemann F, Gedrange T, Biffar R, Kunert-Keil C. Histological evaluation at different times after augmentation of extraction sites grafted with a magnesium-enriched hydroxyapatite: double- blinded randomized controlled trial. Clin Oral Implants Res 2013;24(4):398-406.
219. Aina V, Lusvardi G, Annaz B, Gibson IR, Imrie FE, Malavasi G, Menabue L, Cerrato G, Martra G. Magnesium- and strontium-co-substituted hydroxyapatite: the effects of doped-ions on the structure and chemico-physical properties. J Mater Sci Mater Med 2012;23(12):2867-79.
220. Bock N, Riminucci A, Dionigi C, Russo A, Tampieri A, Landi E, Goranov VA. A novel route in bone tissue engineering: magnetic biomimetic scaffolds. Acta Biomaterialia 2010;6(3)786-96.
221. Tampieri A, D'Alessandro T, Sandri M, Sprio S, Landi E, Bertinetti L, Panseri S, Pepponi G, Goettlicher J, Bañobre-López M, Rivas J. Intrinsic magnetism and hyperthermia in bioactive Fe-doped hydroxyapatite. Acta Biomater 2012;8(2):843-51.
222. Yamamoto H, Shibata Y, Tachikawa T, Miyazaki T. In vivo performance of two different hydroxyapatite coatings on titanium prepared by discharging in electrolytes. J Biomed Mater Res B Appl Biomater 2006;78(1):211-4.
223. Ohashi N, Nakamura M, Nagai A, Tanaka Y, Sekijima Y, Yamashita K. Comparison of hydroxyapatite with carbonate apatite in osteoclastic cell resorptive activity. Key Eng Mat 2007;361-363:1039-42.
224. Ramchandani M, Robinson D. In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants. J Control Release 1998;54(2):167-75.
225. Orhan Z, Cevher E, Yildiz A, Ahiskali R, Sensoy D, Mülazimoğlu L. Biodegradable microspherical implants containing teicoplanin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis. Arch Orthop Trauma Surg 2010;130(1):135-42.
226. Koort JK, Makinen TJ, Suokas E, Veiranto M, Jalava J, Tormala P, Aro HT. Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant. Acta Orthop 2008;79(2):295-301.
227. Sayin B, Caliş S, Atilla B, Marangoz S, Hincal AA. Implantation of vancomycin microspheres in blend with human/rabbit bone grafts to infected bone defects. J Microencapsul 2006;23(5):553-66.
228. Le Ray AM, Gautier H, Laty MK, Daculsi G, Merle C, Jacqueline C, Hamel A, Caillon J. In vitro and in vivo bactericidal activities of vancomycin dispersed in porous biodegradable poly(epsiloncaprolactone) microparticles. Antimicrob Agents Chemother 2005;49(7):3025-7.
229. Xiong MH, Bao Y, Yang XZ, Zhu YH, Wang J. Delivery of antibiotics with polymeric particles. Adv Drug Deliv Rev 2014;Feb 16. pii: S0169-409X(14)00024-6. doi: 10.1016/j.addr.2014.02.002
230. Vilar G, Tulla-Puche J, Albericio F. Polymers and drug delivery systems. Curr Drug Deliv 2012;9(4):367-94.
231. Sabir MI, Xu X. A review of biodegradable polymeric materials for bone tissue engineering applications. J Mater Sci 2009;44:5713-24.
232. Cameron RE, Kamvari-Moghaddam A. Synthetic bioresorbable polymers. In: Buchanan F, editor. Degradation rate of bioresorbable materials. Cambridge: Woodhead; 2008, p. 43 - 66.
233. Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS. Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy. Int J Nanomedicine 2012;7:4077-88.
234. Kluin OS, van der Mei HC, Busscher HJ, Neut D. Biodegradable vs non-biodegradable antibiotic delivery devices in the treatment of osteomyelitis. Expert Opin Drug Deliv 2013;10(3):341-51.
235. Neut D, Kluin OS, Crielaard BJ, van der Mei HC, Busscher HJ, Grijpma DW. A biodegradable antibiotic delivery system based on poly-(trimethylene carbonate) for the treatment of osteomyelitis. Acta Orthop 2009;80(5):514-9.
236. Lang W. A new method for the removal of chronic bone suppuration. Report on the removal of osteomyelitic and multi-infected tuberculous fistulae by filling the bone cavity with polyamide fibers. Z Orthop Ihre Grenzgeb 1969;106(2):393-413.
237. Gurselt I, Yagmurlu F, Korkusuz F, Hasirci V. In vitro antibiotic release from poly(3-hydroxybutyrateco- 3-hydroxyvalerate) rods. J Microencapsul 2002;19(2):153-64.
238. Chen L, Wang H, Wang J, Chen M, Shang L. Ofloxacin-delivery system of a polyanhydride and polylactide blend used in the treatment of bone infection. J Biomed Mater Res B Appl Biomater 2007;83(2):589-95.
239. Brin YS, Nyska A, Domb AJ, Golenser J, Mizrahi B, Nyska M. Biocompatibility of a polymeric implant for the treatment of osteomyelitis. J Biomater Sci Polym Ed 2009;20(7-8):1081-90.
240. Li LC, Deng J, Stephens D. Polyanhydride implant for antibiotic delivery - from the bench to the clinic. Adv Drug Deliv Rev 2002;54(7):963-86.
241. Moskowitz JS, Blaisse MR, Samuel RE, Hsu HP, Harris MB, Martin SD, Lee JC, Spector M, Hammond PT. The effectiveness of the controlled release of gentamicin from polyelectrolyte multilayers in the treatment of Staphylococcus aureus infection in a rabbit bone model. Biomaterials 2010;31(23):6019-30.
242. Wei G, Kotoura Y, Oka M, Yamamuro T, Wada R, Hyon SH, Ikada Y. A bioabsorbable delivery system for antibiotic treatment of osteomyelitis: the use of lactic acid oligomer as a carrier. J Bone Joint Surg [Br] 1991;73-B:246-52.
243. Garvin K, Feschuk C. Polylactide-polyglycolide antibiotic implants. Clin Orthop Relat Res 2005;437:105-10.
244. Koort JK, Makinen TJ, Suokas E, Veiranto M, Jalava J, Tormala P, Aro HT. Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant. Acta Orthop 2008;79(2):295-301.
245. Bostman OM. Osteotic changes accompanying degradation of absorbable fracture fixation implants. J Bone Joint Surg 1991;73(4):679-82.
246. Bostman O, Hirvensalo E, Mikinen J, Rokkanen P. Foreign-body reaction to fracture fixation implants of biodegradable synthetic polymers. J Bone Joint Surg 1990;72(4):592-6.
247. Solheim E, Sudmann B, Bang G, Sudmann E. Biocompatibility and effect on osteogenesis of poly(ortho ester) compared to poly(DL-lactic acid). J Biomed Mater Res 2000;49(2):257-63.
248. Tiainen J, Soini Y, Suokas E, Veiranto M, Törmälä P, Waris T, Ashammakhi N. Tissue reactions to bioabsorbable ciprofloxacin-releasing polylactide-polyglycolide 80/20 screws in rabbits' cranial bone. J Mater Sci Mater Med 2006;17(12):1315-22.
249. Plachokova A, Link D, van den Dolder J, van den Beucken J, Jansen J. Bone regenerative properties of injectable PGLA-CaP composite with TGF-beta1 in a rat augmentation model. J Tissue Eng Regen Med 2007;1(6):457-64.
250. Lemaire S, Van Bambeke F, Pierard D, Appelbaum PC, Tulkens PM. Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin. Clin Infect Dis 2011;52(Suppl 7):S493-503.
251. Middleton JC, Tripton AJ. Synthetic biodegradable polymers as orthopaedic devices. Biomaterials 2000;21:2334-46.
252. Ouédraogo M, Semdé R, Somé IT, Traoré-Ouédraogo R, Guissou IP, Henschel V, Dubois J, Amighi K, Evrard B. Monoolein-water liquid crystalline gels of gentamicin as bioresorbable implants for the local treatment of chronic osteomyelitis: in vitro characterization. Drug Dev Ind Pharm 2008;34(7):753-60.
253. Xiong MH, Li YJ, Bao Y, Yang XZ, Hu B, Wang J. Bacteria-responsive multifunctional nanogel for targeted antibiotic delivery. Adv Mater 2012;24(46):6175-80.
254. Semdé R, Gondi RF, Sombié BC, Yaméogo BG, Ouédraogo M. Effect of hydroxyapatite on the physicochemical characteristics of a gentamicin-loaded monoolein gel intended to treat chronic osteomyelitis. J Adv Pharm Technol Res 2012;3(2):100-5.
255. Zhou J, Fang T, Wang Y, Dong J. The controlled release of vancomycin in gelatin/β-TCP composite scaffolds. J Biomed Mater Res A 2012;100(9):2295-301.
256. Hasegawa M, Sudo A, Komlev VS, Barinov SM, Uchida A. High release of antibiotic from a novel hydroxyapatite with bimodal pore size distribution. J Biomed Mater Res B Appl Biomater 2004;15;70(2):332-9.
257. Della Porta G, Adami R, Del Gaudio P, Prota L, Aquino R, Reverchon E. Albumin/gentamicin microspheres produced by supercritical assisted atomization: optimization of size, drug loading and release. J Pharm Sci 2010;99(11):4720-9.
258. Haswani DK, Nettey H, Oettinger C, D'Souza MJ. Formulation, characterization and pharmacokinetic evaluation of gentamicin sulphate loaded albumin microspheres. J Microencapsul 2006;23(8):875-86.
259. Aquino RP, Auriemma G, Mencherini T, Russo P, Porta A, Adami R, Liparoti S, Della Porta G, Reverchon E, Del Gaudio P. Design and production of gentamicin/dextrans microparticles by supercritical assisted atomisation for the treatment of wound bacterial infections. Int J Pharm 2013;440(2):188-94.
260. Weszl M, Skaliczki G, Cselenyák A, Kiss L, Major T, Schandl K, Bognár E, Stadler G, Peterbauer A, Csönge L, Lacza Z. Freeze-dried human serum albumin improves the adherence and proliferation of mesenchymal stem cells on mineralized human bone allografts. J Orthop Res 2012;30(3):489-96.
261. Skaliczki G, Schandl K, Weszl M, Major T, Kovács M, Skaliczki J, Szendrői M, Dobó-Nagy C, Lacza Z. Serum albumin enhances bone healing in a nonunion femoral defect model in rats: a computer tomography micromorphometry study. Int Orthop 2013;37(4):741-5.
262. Kuechle DK, Landon GC, Musher DM, Noble PC. Elution of vancomycin, daptomycin, and amikacin from acrylic bone cement. Clin Orthop Relat Res 1991;(264):302-8.
263. Zhou J, Fang T, Wen J, Shao Z, Dong J. Silk coating on poly(ε-caprolactone) microspheres for the delayed release of vancomycin. J Microencapsul 2011;28(2):99-107.
264. Ziv K, Nuhn H, Ben-Haim Y, Sasportas LS, Kempen PJ, Niedringhaus TP, Hrynyk M, Sinclair R, Barron AE, Gambhir SS. A tunable silk-alginate hydrogel scaffold for stem cell culture and transplantation. Biomaterials 2014;35:3736-43.
265. Cevher E, Orhan Z, Mülazimoğlu L, Sensoy D, Alper M, Yildiz A, Ozsoy Y. Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres. Int J Pharm 2006;317(2):127-35.
266. Aimin C, Chunlin H, Juliang B, Tinyin Z, Zhichao D. Antibiotic loaded chitosan bar. An in vitro, in vivo study of a possible treatment for osteomyelitis. Clin Orthop Relat Res 1999;(366):239-47.
267. Uskoković V, Desai TA. In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis. J Pharm Sci 2014;103(2):567-79.
268. Sandolo C, Péchiné S, Le Monnier A, Hoys S, Janoir C, Coviello T, Alhaique F, Collignon A, Fattal E, Tsapis N. Encapsulation of Cwp84 into pectin beads for oral vaccination against Clostridium difficile. Eur J Pharm Biopharm 2011;79(3):566-73.
269. Désévaux C, Lenaerts V, Girard C, Dubreuil P. Characterization of crosslinked high amylose starch matrix implants. 2. In vivo release of ciprofloxacin. J Control Release 2002;82(1):95-103.
270. Ueng SW, Lee MS, Lin SS, Chan EC, Liu SJ. Development of a biodegradable alginate carrier system for antibiotics and bone cells. J Orthop Res 2007;25(1):62-72.
271. Matsuno H, Yudoh K, Hashimoto M, Himeda Y, Miyoshi T, Yoshida K, Kano S. A new antibacterial carrier of hyaluronic acid gel. J Orthop Sci 2006;11(5):497-504.
272. Orhan Z, Cevher E, Mülazimoglu L, Gürcan D, Alper M, Araman A, Ozsoy Y. The preparation of ciprofloxacin hydrochloride-loaded chitosan and pectin microspheres: their evaluation in an animal osteomyelitis model. J Bone Joint Surg Br 2006;88(2):270-5.
273. Huneault LM, Lussier B, Dubreuil P, Chouinard L, Désévaux C. Prevention and treatment of experimental osteomyelitis in dogs with ciprofloxacin-loaded crosslinked high amylose starch implants. J Orthop Res 2004;22(6):1351-7.
274. Xing J, Hou T, Luobu B, Luo F, Chen Q, Li Z, Jin H, Xu J. Anti-infection tissue engineering construct treating osteomyelitis in rabbit tibia. Tissue Eng Part A 2013;19(1-2):255-63.
275. Knaepler H. Local application of gentamicin-containing collagen implant in the prophylaxis and treatment of surgical site infection in orthopaedic surgery. Int J Surg 2012;10(Suppl 1):S15-20.
276. Mendel V, Simanowski HJ, Scholz HC, Heymann H. Therapy with gentamicin-PMMA beads, gentamicin- collagen sponge, and cefazolin for experimental osteomyelitis due to Staphylococcus aureus in rats. Arch Orthop Trauma Surg 2005;125(6):363-8.
277. Chaudhary S, Sen RK, Saini UC, Soni A, Gahlot N, Singh D. Use of gentamicin-loaded collagen sponge in internal fixation of open fractures. Chin J Traumatol 2011;14(4):209-14.
278. Kanellakopoulou K, Giamarellos-Bourboulis EJ. Carrier systems for the local delivery of antibiotics in bone infections. Drugs 2000;59(6):1223-32.
279. Kawalec-Carroll JS, Hetherington VJ, Dockery DS, Shive C, Targoni OS, Lehmann PV, Nadler D, Prins D. Immunogenicity of unprocessed and photooxidized bovine and human osteochondral grafts in collagen-sensitive mice. BMC Musculoskelet Disord 2006;7:32.
280. Browne S, Zeugolis DI, Pandit A. Collagen: finding a solution for the source. Tissue Eng Part A 2013;19(13-14):1491-4.
281. Patino MG, Neiders ME, Andreana S, Noble B, Cohen RE. Collagen as an implantable material in medicine and dentistry. J Oral Implantol 2002;28(5):220-5.
282. Park SN, Kim JK, Suh H. Evaluation of antibiotic-loaded collagen-hyaluronic acid matrix as a skin substitute. Biomaterials 2004;25(17):3689-98.
283. Cui F, Li G, Huang J, Zhang J, Lu M, Lu W, Huan J, Huang Q. Development of chitosan-collagen hydrogel incorporated with lysostaphin (CCHL) burn dressing with anti-methicillin-resistant Staphylococcus aureus and promotion wound healing properties. Drug Deliv 2011;18(3):173-80.
284. Lynn AK, Yannas IV, Bonfield W. Antigenicity and immunogenicity of collagen. J Biomed Mater Res B: Appl Biomater 2004;71:343-54.
285. Akturk O, Tezcaner A, Bilgili H, Deveci MS, Gecit MR, Keskin D. Evaluation of sericin/collagen membranes as prospective wound dressing biomaterial. J Biosci Bioeng 2011;112(3):279-88.
286. Ipsen T, Jørgensen PS, Damholt V, Tørholm C. Gentamicin-collagen sponge for local applications. 10 cases of chronic osteomyelitis followed for 1 year. Acta Orthop Scand 1991;62(6):592-4.
287. Sørensen TS, Sørensen AI, Merser S. Rapid release of gentamicin from collagen sponge. In vitro comparison with plastic beads. Acta Orthop Scand 1990;61(4):353-6.
288. Hou J, Wang J, Cao L, Qian Z, Xing W, Lu J, Liu C. Segmental bone regeneration using rhBMP- 2-loaded collagen/chitosan microspheres composite scaffold in a rabbit model. Biomed Mat 2012;7:035002.
289. Kundu B, Nandi SK, Dasgupta S, Datta S, Mukherjee P, Roy S, Singh AK, Mandal TK, Das P, Bhattacharya R, Basu D. Macro-to-micro porous special bioactive glass and ceftriaxone-sulbactam composite drug delivery system for treatment of chronic osteomyelitis: an investigation through in vitro and in vivo animal trial. J Mater Sci Mater Med 2011;22(3):705-20.
290. Xie Z, Liu X, Jia W, Zhang C, Huang W, Wang J. Treatment of osteomyelitis and repair of bone defect by degradable bioactive borate glass releasing vancomycin. J Control Release 2009;139: 118-26.
291. Zhang X, Jia W, Gu Y, Xiao W, Liu X, Wang D, Zhang C, Huang W, Rahaman MN, Day DE, Zhou N. Teicoplanin-loaded borate bioactive glass implants for treating chronic bone infection in a rabbit tibia osteomyelitis model. Biomaterials 2010;31(22):5865-74.
292. Thanyaphoo S, Kaewsrichan J. Synthesis and evaluation of novel glass ceramics as drug delivery systems in osteomyelitis. J Pharm Sci 2012;101(8):2870-82.
293. Valappil SP, Pickup DM, Carroll DL, Hope CK, Pratten J, Newport RJ, Smith ME, Wilson M, Knowles JC. Effect of silver content on the structure and antibacterial activity of silver-doped phosphatebased glasses. Antimicrob Agents Chemother 2007;51(12):4453-61.
294. Aughenbaugh W, Radin S, Ducheyne P. Silica sol-gel for the controlled release of antibiotics. II. The effect of synthesis parameters on the in vitro release kinetics of vanomycin. J Biomed Mater Res 2001;57(3):321-6.
295. Pavelić K, Hadžija M. Medical applications of zeolites, In: Auerbach SM, Carrado KA, Dutta PK, editors. Handbook of zeolite science and technology. New York: Marcel Dekker; 2005, p. 1460.
296. Rhodes CJ. Properties and applications of zeolites. Sci Prog 2010;93(3):223-84.
297. Banu J, Varela E, Guerra JM, Halade G, Williams PJ, Bahadur AN, Hanaoka K, Fernandes G. Dietary coral calcium and zeolite protects bone in a mouse model for postmenopausal bone loss. Nutr Res 2012;32(12):965-75.
298. Schütze N, Oursler MJ, Nolan J, Riggs BL, Spelsberg TC. Zeolite A inhibits osteoclast-mediated bone resorption in vitro. J Cell Biochem 1995;58(1):39-46.
299. Harrison RG, Fox OD, Meng MO, Dalley NK, Barbour LJ. Cation control of pore and channel size in cage-based metal-organic porous materials. Inorg Chem 2002;41(4):838-43.
300. Chen Y, Lykourinou V, Vetromile C, Hoang T, Ming LJ, Larsen R, Ma S. How can proteins enter the interior of a MOF? Investigation of cytochrome c translocation into a MOF consisting of mesoporous cages with microporous windows. J Am Chem Soc 2012;134:13188-91.
301. Vallet-Regí M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed Engl 2007;46(40):7548-58.
302. Hanke M, Arslan HK, Bauer S, Zybaylo O, Christophis C, Gliemann H, Rosenhahn A, Wöll C. The biocompatibility of metal-organic framework coatings: an investigation on the stability of SURMOFs with regard to water and selected cell culture media. Langmuir 2012;28(17):6877-84.
303. Seil JT, Webster TJ. Antimicrobial applications of nanotechnology: methods and literature. Int J Nanomedicine 2012;7:2767-81.
304. Wilkinson LJ, White RJ, Chipman JK. Silver and nanoparticles of silver in wound dressings: a review of efficacy and safety. J Wound Care 2011;20(11):543-9.
305. Monteiro DR, Gorup LF, Takamiya AS, Ruvollo-Filho AC, de Camargo ER, Barbosa DB. The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver. Int J Antimicrob Agents 2009;34(2):103-10.
306. Becker RO. Silver ions in the treatment of local infections. Met Based Drugs 1999;6:311-4.
307. Gulati K, Aw MS, Losic D. Drug-eluting Ti wires with titania nanotube arrays for bone fixation and reduced bone infection. Nanoscale Res Lett 2011;6:571.
308. Popat KC, Eltgroth M, Latempa TJ, Grimes CA, Desai TA. Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials 2007;28(32):4880-8.
309. Peng L, Mendelsohn AD, LaTempa TJ, Yoriya S, Grimes CA, Desai TA. Long-term small molecule and protein elution from TiO2 nanotubes. Nano Lett 2009;9(5):1932-6.
310. Harris LG, Meredith DO, Eschbach L, Richards RG. Staphylococcus aureus adhesion to standard micro-rough and electropolished implant materials. J Mater Sci Mater Med 2007;18(6):1151-6.
311. Gristina AG. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 1987;237:1588-95.
312. Kirkham J, Brookes SJ, Shore RC, Wood SR, Smith DA, Zhang J, Chen H, Robinson C. Physicochemical properties of crystal surfaces in matrix-mineral interactions during mammalian biomineralisation. Curr Opin Coll Interface Sci 2002;7:124-32.
313. Müller B. Tailoring biocompatibility: benefitting patients. Mat Today 2010;13(4):58.
314. Sisti KE, Piattelli A, Guastaldi AC, Queiroz TP, de Rossi R. Nondecalcified histologic study of bone response to titanium implants topographically modified by laser with and without hydroxyapatite coating. Int J Periodontics Restorative Dent 2013;33(5):689-96.
315. Hirota M, Hayakawa T, Yoshinari M, Ametani A, Shima T, Monden Y, Ozawa T, Sato M, Koyama C, Tamai N, Iwai T, Tohnai I. Hydroxyapatite coating for titanium fibre mesh scaffold enhances osteoblast activity and bone tissue formation. Int J Oral Maxillofac Surg 2012;41(10):1304-9.
316. Murakami A, Arimoto T, Suzuki D, Iwai-Yoshida M, Otsuka F, Shibata Y, Igarashi T, Kamijo R, Miyazaki T. Antimicrobial and osteogenic properties of a hydrophilic-modified nanoscale hydroxyapatite coating on titanium. Nanomedicine 2012;8(3):374-82.
317. Zavgorodniy AV, Borrero-López O, Hoffman M, Legeros RZ, Rohanizadeh R. Characterization of the chemically deposited hydroxyapatite coating on a titanium substrate. J Mater Sci Mater Med 2011;22(1):1-9.
318. Uskoković V, Hoover C, Vukomanović M, Uskoković DP, Desai TA. Osteogenic and antimicrobial nanoparticulate calcium phosphate and/or poly-lactide-co-glycolide powders for the treatment of osteomyelitis. Mat Sci Eng C: Mat Bio Appl 2013;33(6):3362-73.
319. Tamazawa G, Ito A, Miyai T, Matsuno T, Kitahara K, Sogo Y, Kimishima K, Satoh T. Gatifloxacine- loaded PLGA and β-tricalcium phosphate composite for treating osteomyelitis. Dent Mater J 2011;30(3):264-73.
320. Fang T, Wen J, Zhou J, Shao Z, Dong J. Poly (ε-caprolactone) coating delays vancomycin delivery from porous chitosan/β-tricalcium phosphate composites. J Biomed Mater Res B Appl Biomater 2012;100B(7):1803-11.
321. Sokolova V, Knuschke T, Buer J, Westendorf AM, Epple M. Quantitative determination of the composition of multi-shell calcium phosphate-oligonucleotide nanoparticles and their application for the activation of dendritic cells. Acta Biomater 2011;7(11):4029-36.
322. Cheng J, Teply BA, Sherifi I, Sung J, Luther G, Gu FX, Levy-Nissenbaum E, Radovic-Moreno AF, Langer R, Farokhzad OC. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 2007;28:869-76.
323. Wang RE, Costanza F, Niu Y, Wu H, Hu Y, Hang W, Sun Y, Cai J. Development of self-immolative dendrimers for drug delivery and sensing. J Control Release 2012;159(2):154-63.
324. Mochalin VN, Neitzel I, Etzold BJ, Peterson A, Palmese G, Gogotsi Y. Covalent incorporation of aminated nanodiamond into an epoxy polymer network. ACS Nano 2011;5(9):7494-502.
325. Zhang Z, Ma R, Shi L. Cooperative macromolecular self-assembly toward polymeric assemblies with multiple and bioactive functions. Acc Chem Res 2014;47(4):1426-37.
326. Naito K, Obayashi O, Mogami A, Itoi A, Kaneko K. Fracture of the calcium phosphate bone cement which used to enchondroma of the hand, a case report. Eur J Orthop Surg Traumatol 2008;18:405-8.
327. Rezwan K, Chen Q, Blaker J, Boccaccini A. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 2006;27(18):3413-31.
328. Bucholz RW. Nonallograft osteoconductive bone graft substitutes. Clin Orthop Relat Res 2002;395:44-52.
329. Alge DL, Bennett J, Treasure T, Voytik-Harbin S, Goebel WS, Chu TMG. Poly(propylene fumarate) reinforced dicalcium phosphate dihydrate cement composites for bone tissue engineering. J Biomed Mater Res A 2012;100A:1792-802.
330. Fernández E, Sarda S, Hamcerencu M, Vlad MD, Gel M, Valls S, Torres R, López J. High-strength apatitic cement by modification with superplasticizers. Biomaterials 2005;26:2289-96.
331. Fujishiro Y, Takahashi K, Sato T. Preparation and compressive strength of α-tricalcium phosphate/ gelatin gel composite cement. J Biomed Mater Res 2001;54:525-30.
332. dos Santos LA, Carrodeguas RG, Boschi AO, de Arruda ACF. Dual-setting calcium phosphate cement modified with ammonium polyacrylate. Artif Organs 2003;27:412-8.
333. Mickiewicz RA, Mayes AM, Knaack D. Polymer - calcium phosphate cement composites for bone substitutes. J Biomed Mater Res 2002;61:581-92.
334. Miyazaki K, Horibe T, Antonucci JM, Takagi S, Chow LC. Polymeric calcium phosphate cements: setting reaction modifiers. Dent Mater 1993;9:46-50.
335. Komath M, Varma HK. Development of a fully injectable calcium phosphate cement for orthopedic and dental applications. Bull Mater Sci 2003;26:415-22.
336. Ajduković Z, Ignjatović N, Petrović, Uskoković D. Substitution of osteoporotic alveolar bone by biphasic calcium phosphate/poly-DL-lactide-co-glycolide biomaterials. J Biomaterials Appl 2007;21(3):317-28.
337. Ruhé PQ, Hedberg EL, Padron NT, Spauwen PH, Jansen JA, Mikos AG. Biocompatibility and degradation of poly(DL-lactic-co-glycolic acid)/calcium phosphate cement composites. J Biomed Mater Res A 2005;74(4):533-44.
338. Félix Lanao RP, Leeuwenburgh SC, Wolke JG, Jansen JA. Bone response to fast-degrading, injectable calcium phosphate cements containing PLGA microparticles. Biomaterials 2011;32(34): 8839-47.
339. Link DP, van den Dolder J, Jurgens WJ, Wolke JG, Jansen JA. Mechanical evaluation of implanted calcium phosphate cement incorporated with PLGA microparticles. Biomaterials 2006;27(28):4941-7.
340. Shi P, Zuo Y, Li X, Zou Q, Liu H, Zhang L, Li Y, Morsi YS. Gentamicin-impregnated chitosan/nanohydroxyapatite/ ethyl cellulose microspheres granules for chronic osteomyelitis therapy. J Biomed Mater Res A 2010;93(3):1020-31.
341. Romeo HE, Fanovich MA. Functionalized bridged silsesquioxane-based nanostructured microspheres: performance as novel drug-delivery devices in bone tissue-related applications. J Biomater Appl 2012;26(8):987-1012.
342. Fang T, Wen J, Zhou J, Shao Z, Dong J. Poly (ε-caprolactone) coating delays vancomycin delivery from porous chitosan/β-tricalcium phosphate composites. J Biomed Mater Res B Appl Biomater 2012;100B(7):1803-11.
343. Miki T, Imai Y. Osteoinductive potential of freeze-dried, biodegradable, poly (glycolic acid-co-lactic acid) disks incorporated with bone morphogenetic protein in skull defects of rats. Int J Oral Maxillofac Surg 1996;25(5):402-6.
344. Jensen T, Baas J, Dolathshahi-Pirouz A, Jacobsen T, Singh G, Nygaard JV, Foss M, Bechtold J, Bünger C, Besenbacher F, Søballe K. Osteopontin functionalization of hydroxyapatite nanoparticles in a PDLLA matrix promotes bone formation. J Biomed Mater Res A 2011;99(1):94-101.
345. Ji Y, Xu GP, Zhang ZP, Xia JJ, Yan JL, Pan SH. BMP-2/PLGA delayed-release microspheres composite graft, selection of bone particulate diameters, and prevention of aseptic inflammation for bone tissue engineering. Ann Biomed Eng 2010;38(3):632-9.
346. Yoon SJ, Kim SH, Ha HJ, Ko YK, So JW, Kim MS, Yang YI, Khang G, Rhee JM, Lee HB. Reduction of inflammatory reaction of poly(d,l-lactic-co-glycolic acid) using demineralized bone particles. Tissue Eng Part A 2008;14(4):539-47.
347. Gyenes T, Torma V, Gyarmati B, Zrínyi M. Synthesis and swelling properties of novel pH-sensitive poly(aspartic acid) gels. Acta Biomater 2008;4(3):733-44.
348. Jeong B, Kim SW, Bae YH. Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev 2012;64:154-62.
349. Peng KT, Chen CF, Chu IM, Li YM, Hsu WH, Hsu RW, Chang PJ. Treatment of osteomyelitis with teicoplanin-encapsulated biodegradable thermosensitive hydrogel nanoparticles. Biomaterials 2010;31(19):5227-36.
350. Ma T, Shang BC, Tang H, Zhou TH, Xu GL, Li HL, Chen QH, Xu YQ. Nano-hydroxyapatite/chitosan/ konjac glucomannan scaffolds loaded with cationic liposomal vancomycin: preparation, in vitro release and activity against Staphylococcus aureus biofilms. J Biomater Sci Polym Ed 2011;22(12):1669-81.
351. Zhu CT, Xu YQ, Shi J, Li J, Ding J. Liposome combined porous beta-TCP scaffold: preparation, characterization, and anti-biofilm activity. Drug Deliv 17(6):391-8 (2010).
352. Pagliari F, Mandoli C, Forte G, Magnani E, Pagliari S, Nardone G, Licoccia S, Minieri M, Di Nardo P, Traversa E. Cerium oxide nanoparticles protect cardiac progenitor cells from oxidative stress. ACS Nano 2012;6(5):3767-75.
353. Stevanović M, Savić J, Jordović B, Uskoković D. Fabrication, in vitro degradation and the release behaviours of poly(DL-lactide-co-glycolide) nanospheres containing ascorbic acid. Coll Surf B: Biointerfaces 2007;59:215-23.
354. Schwegmann H, Feitz AJ, Frimmel FH. Influence of the zeta potential on the sorption and toxicity of iron oxide nanoparticles on S. cerevisiae and E. coli. J Coll Interface Sci 2010;347(1):43-8.
355. Uskoković V. Dynamic light scattering and microelectrophoresis: main prospects and limitations. J Disp Sci Tech 2012;33(12):1762-86.
356. Beech JA. Bioelectric potential gradients may initiate cell cycling: ELF and zeta potential gradients may mimic this effect. Bioelectromagnetics 1997;18(5):341-8.
357. Uskoković V. Theoretical and practical aspects of colloid science and self-assembly phenomena revisited. Rev Chem Eng 2007;23(5):301-72.
358. Silvestrini MT, Yin D, Coppes VG, Mann P, Martin AJ, Larson PS, Starr PA, Gupta N, Panter SS, Desai TA, Lim DA. Radially branched deployment for more efficient cell transplantation at the scale of the human brain. Stereotact Funct Neurosurg 2013;91(2):92-103.
359. Stepensky D, Kleinberg L, Hoffman A. Bone as an effect compartment: models for uptake and release of drugs. Clin Pharmacokinet 2003;42(10):863-81.
360. Bessa PC, Casal M, Reis RL. Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2008;2:81-96.
361. Mistry AS, Mikos AG. Tissue engineering strategies for bone regeneration. Adv Biochem Engin/ Biotechnol 2005;94:1-22.
362. Ma X, Zhao Y, Liang XJ. Theranostic nanoparticles engineered for clinic and pharmaceutics. Acc Chem Res 2011;44(10):1114-22.
363. Mehta M, Schmidt-Bleek K, Duda GN, Mooney DJ. Biomaterial delivery of morphogens to mimic the natural healing cascade in bone. Adv Drug Deliv Rev 2012;64(12):1257-76.
364. Nair SP, Meghji S, Wilson M, Reddi K, White P, Henderson B. Bacterially induced bone destruction: mechanisms and misconceptions. Infect Immun 1996;64(7):2371-80.
365. Stallmann HP, Faber C, Nieuw Amerongen AV, Wuisman PI. Antimicrobial peptides: review of their application in musculoskeletal infections. Injury 2006;37(Suppl 2):S34-40.
366. Niu Y, Wang RE, Wu H, Cai J. Recent development of small antimicrobial peptidomimetics. Future Med Chem 2012;4(14):1853-62.
367. Girard PP, Cavalcanti-Adam EA, Kemkemer R, Spatz JP. Cellular chemomechanics at interfaces: sensing, integration and response. Soft Matter 2007;3:307-26.
368. Panahifar A, Mahmoudi M, Doschak MR. Synthesis and in vitro evaluation of bone-seeking superparamagnetic iron oxide nanoparticles as contrast agents for imaging bone metabolic activity. ACS Appl Mater Interfaces 2013;5:5219-26.
369. Yewle JN, Puleo DA, Bachas LG. Enhanced affinity bifunctional bisphosphonates for targeted delivery of therapeutic agents to bone. Bioconjug Chem 2011;22(12):2496-506.
370. Das S, Crockett JC. Safety issues with bisphosphonate therapy for osteoporosis. Drug Des Devel Ther 2013;7:435-48.
371. Verron E, Bouler JM. Is bisphosphonate therapy compromised by the emergence of adverse bone disorders? Drug Discov Today 2014;19(3):312-9.
372. Suresh E, Pazianas M, Abrahamsen B. Safety issues with bisphosphonate therapy for osteoporosis. Rheumatology (Oxford) 2014;53:19-31.
373. Wahlig H. Gentamicin-PMMA beads, a drug delivery system: basic results. In: van Rens TJG, Kayser FH, editors. Local antibiotic treatment in osteomyelitis and soft-tissue infections: Proceedings of a symposium, Amsterdam, October 25, 1980. Amstewrdam: Excerpta Medica; 1981.
374. Nehilla BJ, Allen PG, Desai TA. Surfactant-free, drug-quantum-dot coloaded poly(lactide-co-glycolide) nanoparticles: towards multifunctional nanoparticles. ACS Nano 2008;2(3):528-44.
375. Guo Y, Shi DL, Lian J, Dong ZY, Wang W, Cho HS, Liu GK, Wang LM, Ewing RC. Quantum dot conjugated hydroxylapatite nanoparticles for in vivo imaging. Nanotechnology 2008;19(17): 175102.
376. Wu P, Yan XP. Doped quantum dots for chemo/biosensing and bioimaging. Chem Soc Rev 2013;42(12):5489-521.
377. Zhang Y, Yang J. Design strategies for fluorescent biodegradable polymeric biomaterials. J Mater Chem B Mater Biol Med 2013;1(2):132-48.
378. Yang J, Zhang Y, Gautam S, Liu L, Dey J, Chen W, Mason RP, Serrano CA, Schug KA, Tang L. Development of aliphatic biodegradable photoluminescent polymers. Proc Natl Acad Sci U S A. 2009;106(25):10086-91.
379. Al-Sokanee ZN, Toabi AA, Al-Assadi MJ, Alassadi EA. The drug release study of ceftriaxone from porous hydroxyapatite scaffolds. AAPS PharmSciTech 2009;10(3):772-9.
380. Nilsson M, Fernández E, Sarda S, Lidgren L, Planell JA. Characterization of a novel calcium phosphate/sulphate bone cement. J Biomed Mater Res 2002;61:600-7.
381. Constantz BR, Barr BM, Ison IC, Fulmer MT, Baker J, McKinney LA, Goodman SB, Gunasekaren S, Delaney DC, Ross J, Poser RD. Histological, chemical and crystallographic analysis of four calcium phosphate cements in different rabbit osseous sites. J Biomed Mater Res B Appl Biomater 1998;43:451-61.
382. Habraken WJEM, de Jonge LT, Wolke JGC, Yubao L, Mikos AG, Jansen JA. Introduction of gelatin microspheres into an injectable calcium phosphate cement. J Biomed Mater Res A 2008;87A:643-55.
383. El-Ghannam A, Ahmed K, Omran M. Nanoporous delivery system to treat osteomyelitis and regenerate bone: gentamicin release kinetics and bactericidal effect. J Biomed Mater Res B Appl Biomater 2005;73(2):277-84.
384. Gultepe E, Nagesha D, Sridhar S, Amiji M. Nanoporous inorganic membranes or coatings for sustained drug delivery in implantable devices. Adv Drug Deliv Rev 2010;62(3):305-15.
385. Lindner M, Bergmann C, Telle R, Fischer H. Calcium phosphate scaffolds mimicking the gradient architecture of native long bones. J Biomed Mater Res A 2013;26:1-8.
386. Zhu Y, Wan Y, Zhang J, Yin D, Cheng W. Manufacture of layered collagen/chitosan-polycaprolactone scaffolds with biomimetic microarchitecture. Coll Surf B: Biointerfaces 2014;113:352-60.
387. Andala DM, Shin SH, Lee HY, Bishop KJ. Templated synthesis of amphiphilic nanoparticles at the liquid-liquid interface. ACS Nano 2012;6(2):1044-50.
388. Marković S, Uskoković D. Barium titanate stannate functionally graded materials: Choosing of the Ti/Sn concentration gradient and the influence of the gradient on electrical properties. Ceram Trans 2010;221:3-17.
389. Hou T, Xu J, Li Q, Feng J, Zen L. In vitro evaluation of a fibrin gel antibiotic delivery system containing mesenchymal stem cells and vancomycin alginate beads for treating bone infections and facilitating bone formation. Tissue Eng Part A 2008;14(7):1173-82.
390. Ueng SW, Yuan LJ, Lin SS, Liu SJ, Chan EC, Chen KT, Lee MS. In vitro and in vivo analysis of a biodegradable poly(lactide-co-glycolide) copolymer capsule and collagen composite system for antibiotics and bone cells delivery. J Trauma 2011;70(6):1503-9.
391. Liu J, Tan Y, Zhang H, Zhang Y, Zu P, Chen J, Poh YC, Tang K, Wang N, Huang B. Soft fibrin gels promote selection and growth of tumorigenic cells. Nature Materials 2012;11(8):734-41.
392. Stevanović M, Savanović I, Uskoković V, Škapin SD, Bračko I, Jovanović U, Uskoković D. A new, simple, green and one-pot four-component synthesis of bare and poly(α, γ, L-glutamic acid) capped silver nanoparticles. Coll Polym Sci 2011;290(3):221-31.
393. Stevanović M, Uskoković V, Filipović M, Škapin SD, Uskoković DP. Composite PLGA/AgNpPGA/ AscH nanospheres with combined osteoinductive, antioxidative and antimicrobial activities. ACS Appl Mat Interfaces 2013;5(18):9034-42.
394. Monopoli MP, Aberg C, Salvati A, Dawson KA. Biomolecular coronas provide the biological identity of nanosized materials. Nature Nanotech 2012;7:779-86.
395. Prapainop K, Witter DP, Wentworth Jr. P. A chemical approach for cell-specific targeting of nanomaterials: small-molecule-initiated misfolding of nanoparticle corona proteins. J Am Chem Soc 2012;134:4100-3.
396. Ignjatović N, Uskoković V, Ajduković Z, Uskoković D. Multifunctional hydroxyapatite and poly(D,Llactide- co-glycolide) nanoparticles for the local delivery of cholecalciferol. Mat Sci Eng C: Bio Appl 2013;33(2):943-50.
397. Narducci P, Nicolin V. Differentiation of activated monocytes into osteoclast-like cells on a hydroxyapatite substrate: an in vitro study. Ann Anatomy 2009;191(4):349-55.
398. Buijs PRA, van Eijck CHJ, Hofland LJ, Fouchier RAM, van den Hoogen BG. Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection. Cancer Gene Ther 2014;21:24-30.
399. Lin HP, Lin CY, Hsiao PH, Wang HD, Sheng Jiang S, Hsu JM, Jim WT, Chen M, Kung HJ, Chuu CP. Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cells. PLoS One 2013;8(12): e82625.
400. Correia AL, Bissell MJ. The tumor microenvironment is a dominant force in multidrug resistance. Drug Resist Updat 2012;15(1-2):39-49.
401. Scheman L, Janota M, Lewin P. The production of experimental osteomyelitis: premilinary report. J Am Med Assoc 1941;177:1525-9.
402. Spagnolo N, Greco F, Rossi A. Chronic Staphylococcal osteomyelitis: a new experimental rat model. Infect Immun 1993;61:5225-30.
403. Gracia E, Lacleriga A, Monzon M. Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms. J Surg Res 1998;79:146-53.
404. Brown KV, Walker JA, Cortez DS, Murray CK, Wenke JC. Earlier debridement and antibiotic administration decrease infection. J Surg Orthop Adv 2010;19:18-22.
405. Nair MB, Kretlow JD, Mikos AG, Kasper FK. Infection and tissue engineering in segmental bone defects - a mini review. Curr Opin Biotechnol 2011;22(5):721-5.
406. Patel M, Rojavin Y, Jamali AA, Wasielewski SJ, Salgado CJ. Animal models for the study of osteomyelitis. Semin Plast Surg 2009;23(2):148-54.
407. Perlroth J, Kuo M, Tan J, Bayer AS, Miller LG. Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature. Arch Intern Med 2008;168(8):805-19.
408. Oh SH, Kang SG, Lee JH. Degradation behaviour of hydrophilized PLGA scaffolds prepared by melt-moulding particulate-leaching method: comparison with control hydrophobic one. J Mat Sci: Mat Med 2006;17:131-7.
409. Tomlins P. Influence of porous structure on bioresorbability: tissue engineering scaffolds. In: Buchanan F, editor. Degradation rate of bioresorbable materials. Cambridge: Woodhead; 2008, p. 234 - 264.
410. Silver IA, Murrills RJ, Etherington DJ. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res 1988;175(2):266-76.
411. Burg KJL, Orr DE. An overview of bioresorbable materials. In: Buchanan F, editor. Degradation rate of bioresorbable materials. Cambridge: Woodhead; 2008, p. 3 - 18.
412. Driessens FCM. Physiology of hard tissues in comparison with the solubility of synthetic calcium phosphates. Ann New York Academy Sci 1988;523:131-6.
413. Driessens FCM, Verbeeck RMH. Relation between physicochemical solubility and biodegradability of calcium phosphates. In: de Putter C, de Lange GL, de Groot K, Lee AJC, editors. Implant materials in biofunction. Amsterdam: Elsevier; 1988, p. 105 - 111.
414. Bohner M. Bioresorbable ceramics. In: Buchanan F, editor. Degradation rate of bioresorbable materials. Cambridge: Woodhead; 2008, p. 95 - 114.
415. Suzuki O, Nakamura M, Miyasaki Y, Kagayama M, Sakurai M. Bone formation on synthetic precursors of hydroxyapatite. Tohoku J Exp Med 1991;164:37-50.
416. Bohner M, Theiss F, Apelt D, Hirsiger W, Houriet R, Rizzoli G, Gnos E, Frei C, Auer JA, von Rechenberg B. Compositional changes of a dicalcium phosphate dihydrate cement after implantation in sheep. Biomaterials 2003;24:3463-74.
417. Penel G, Leroy N, Van Landuyt P, Flautre B, Hardouin P, Lemaître J, Leroy G. Raman microspectrometry studies of brushite cement: in vivo evolution in a sheep model. Bone 1999;25:81S-84S.
418. Elliott JC. Structure and chemistry of the apatites and other calcium orthophosphates. Amsterdam: Elsevier; 1994.
419. Mabilleau G, Sabokbar A. In vitro biological test methods to evaluate bioresorbability. In: Buchanan F, editor. Degradation rate of bioresorbable materials. Cambridge: Woodhead; 2008, p. 145 - 160.
420. Wright GD. The origins of antibiotic resistance. Handb Exp Pharmacol 2012;211:13-30.
421. Yarboro SR, Baum EJ, Dahners LE. Locally administered antibiotics for prophylaxis against surgical wound infection. An in vivo study. J Bone Joint Surg Am 2007;89(5):929-33.
422. Aarts HJM, Guerra B, Malorny B. Molecular methods for detection of antibiotic resistance. In: Aarestrup FM, editor. Antimicrobial resistance in bacteria of animal origin. Washington: American Society for Microbiology Press; 2006, p. 55.
423. Bohner M, Lemaître J, van Landuyt P, Zambelli P, Merkle HP, Gander B. Gentamicin- loaded hydraulic calcium orthophosphate bone cement as antibiotic delivery system. J Pharm Sci 1997;86:565-72.
424. Chen DW, Hsu YH, Liao JY, Liu SJ, Chen JK, Ueng SW. Sustainable release of vancomycin, gentamicin and lidocaine from novel electrospun sandwich-structured PLGA/collagen nanofibrous membranes. Int J Pharm 2012;430(1-2):335-41.
425. Schnettler R, Steinau HU. Septic bone and joint surgery. Stuttgart: Thieme; 2010.
426. Gbureck U, Vorndran E, Muller FA, Barralet JE. Low temperature direct 3D printed bioceramics and biocomposites as drug release matrices. J Control Release 2007;122:173-80.
427. Penner MJ, Masri BA, Duncan CP. Elution characteristics of vancomycin and tobramycin combined in acrylic bone-cement. J Arthroplasty 1996;11(8):939-44.
428. Mani G, Torres N, Oh S. Paclitaxel delivery from cobalt-chromium alloy surfaces using self-assembled monolayers. Biointerphases 2011;6:33-42.
429. Perry AC, Rouse MS, Khaliq Y, Piper KE, Hanssen AD, Osmon DR, Steckelberg JM, Patel R. Antimicrobial release kinetics from polymethylmethacrylate in a novel continuous flow chamber. Clin Orthop Relat Res 2002;403:49-53.
430. Chan JCY, Burugapalli K, Kelly JL, Pandit AS. Influence of clinical application on bioresorbability: host response. In: Buchanan F, editor. Degradation rate of bioresorbable materials. Cambridge: Woodhead; 2008, p. 265 - 318.
431. Beumer GJ, van Blitterswijk CA, Ponec M. Degradative behaviour of polymeric matrices in (sub) dermal and muscle tissue of the rat: a quantitative study. Biomaterials 1994;15:551-9.
432. Bhatia S, Shalaby SW, Powers DL, Lancaster RL, Ferguson RL. The effect of site of implantation and animal age on properties of polydioxanone pins. J Biomater Sci Poly Ed 1994;6:435-46.
433. Claes LE. Mechanical characterization of biodegradable implants. Clin Mater 1992;10:41-6.
434. Hu P, Tirelli N. Scavenging ROS: superoxide dismutase/catalase mimetics by the use of an oxidationsensitive nanocarrier/enzyme conjugate. Bioconjug Chem 2012;23(3):438-49.
435. Parfitt AM. What is the normal rate of bone remodeling? Bone 2004;35:1-3.
436. Almeida RA, Matthews KR, Cifrian E, Guidry AJ, Oliver SP. Staphylococcus aureus invasion of bovine mammary cells. J Dairy Sci 1996;79:1021-6.
437. Bayles KW, Wesson CA, Liou LW, Fox LK, Bohach GA, Trumble WR. Intracellular Staphylococcus aureus escapes the endosome and induces apoptosis in epithelial cells. Infect Immun 1998;66:336-42.
438. Ellington JK, Harris M, Webb L, Smith B, Smith T, Tan K, Hudson M. Intracellular Staphylococcus aures: a mechanism for the indolence of osteomyelitis. J Bone Joint Surg 2003;85B:918-21.
439. Ahmed S, Meghji S, Williams RJ, Henderson B, Brock JH, Nair SP. Staphylococcus aureus fibronectin binding proteins are essential for internalization by osteoblasts but do not account for differences in intracellular levels of bacteria. Infect Immun 2001;69(5):2872-7.
440. Bost KL, Ramp WK, Nicholson NC, Bento JL, Marriott I, Hudson MC. Staphylococcus aureus infection of mouse or human osteoblasts induces high levels of interleukin-6 and interleukin-12 production. J Infect Dis 1999;180(6):1912-20.
441. Hassan MA, Ahmed IS, Campbell P, Kondo T. Enhanced gene transfection using calcium phosphate co-precipitates and low-intensity pulsed ultrasound. Eur J Pharm Sci 2012;47(4):768-73.
442. Cao X, Deng W, Wei Y, Su W, Yang Y, Wei Y, Yu J, Xu X. Encapsulation of plasmid DNA in calcium phosphate nanoparticles: stem cell uptake and gene transfer efficiency. Int J Nanomedicine 2011;6:3335-49.
443. Elangovan S, Jain S, Tsai PC, Margolis HC, Amiji M. Nano-sized calcium phosphate particles for periodontal gene therapy. J Periodontol 2013;84(1):117-25.
444. Uskoković V, Desai TA. Simultaneous bactericidal and osteogenic effect of nanoparticulate calcium phosphate powders loaded with clindamycin on osteoblasts infected with Staphylococcus aureus. Mat Sci Eng C: Mat Bio Appl 2014;37:210-22.
445. Pillai R, Somayaji SN, Rabinovich M, Hudson MC, Gonsalves KE. Nafcillin-loaded PLGA nanoparticles for treatment of osteomyelitis. Biomed Mater 2008;3:034114.
446. Dee KC, Bizios R. Mini-review: Proactive biomaterials and bone tissue engineering. Biotechnol Bioeng 1996;50(4):438-42.
447. Sergent JA, Paget V, Chevillard S. Toxicity and genotoxicity of nano-SiO2 on human epithelial intestinal HT-29 cell line. Ann Occup Hyg 2012;56(5):622-30.
448. Nouri A, Castro R, Santos JL, Fernandes C, Rodrigues J, Tomás H. Calcium phosphate-mediated gene delivery using simulated body fluid (SBF). Int J Pharm 2012;434(1-2):199-208.
449. dos Santos T, Varela J, Lynch I, Salvati A, Dawson KA. Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines. Small 2011;7(23):3341-9.
450. Murakami T, Murakami H, Ramp WK, Hudson MC, Nousiainen MT. Calcium hydroxide ameliorates tobramycin toxicity in cultured chick tibiae. Bone 1997;21(5):411-8.
451. Uskoković V. Challenges for the modern science in its descend towards nano scale. Current Nanosci 2009;5(3):372-89.
452. Sheldrake R. Morphic resonance: the nature of formative causation. Rochester: Park Street Press; 2009, p. 96-97.
453. Uskoković V, Desai TA. Phase composition control of calcium phosphate nanoparticles for tunable drug delivery kinetics and treatment of osteomyelitis. Part 2: antibacterial and osteoblastic response. J Biomed Mat Res Part A 2013;101:1427-36.
454. DeLongchamp D. Structure measurements for organic photovoltaics manufacturing. Materials Research Society Conference: Symposium JJ, San Francisco, CA; April 4, 2013.
455. Uskoković V. Insights into morphological nature of precipitation of cholesterol. Steroids 2008;73: 356-69.
456. Horbett TA. Adsorbed proteins on biomaterials. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE, editors. Biomaterials science. Amsterdam: Academic Press; 2012, p. 394 - 408.
457. Malaiya A, Vyas SP. Preparation and characterization of indomethacin magnetic nanoparticles. J Microencapsul 1998;5:243-53.
458. Debuigne F, Jeunieau L, Wiame M, Nagy JB. Synthesis of organic nanoparticles in different W/O microemulsions. Langmuir 2000;16:7605-11.
459. Madsen HEL. Influence of magnetic field on the precipitation of some inorganic salts. J Crystal Growth 1995;152:94-100.
460. Reitas AMBF, Andgraf FJGL, Yvlt JN, Iuletti MG. Influence of magnetic field in the kinetics of crystallization of diamagnetic and paramagnetic inorganic salts. Crystal Res Tech 1999;34:1239-44.
461. Baker A, Tóth A, Horváth D, Walkush J, Ali AS, Morgan W, Kukovecz A, Pantaleone JJ, Maselko J. Precipitation pattern formation in the copper(II) oxalate system with gravity flow and axial symmetry. J Phys Chem A 2009;113(29):8243-8.
462. Stiles PJ, Fletcher DF, Morris I. The effect of gravity on the rates of simple liquid-state reactions in a small, unstirred cylindrical vessel. Part II. Phys Chem Chem Phys 2001;3:3651-5.
463. Saxena R, Pan G, McDonald JM. Osteoblast and osteoclast differentiation in modeled microgravity. Ann N Y Acad Sci 2007;1116:494-8.
464. Zayzafoon M, Gathings WE, McDonald JM. Modeled microgravity inhibits osteogenic differentiation of human mesenchymal stem cells and increases adipogenesis. Endocrinology. 2004;145(5):2421-32.
465. Huang Y, Dai ZQ, Ling SK, Zhang HY, Wan YM, Li YH. Gravity, a regulation factor in the differentiation of rat bone marrow mesenchymal stem cells. J Biomed Sci 2009;16:87.
466. Muralithran G, Ramesh S. The effects of sintering temperature on the properties of hydroxyapatite. Ceram Int 2000;26:221-30.
467. Oliver CR, Polsen ES, Meshot ER, Tawfick S, Park SJ, Bedewy M, Hart AJ. Statistical analysis of variation in laboratory growth of carbon nanotube forests and recommendations for improved consistency. ACS Nano 2013;7(4):3565-80.
468. Lacruz RS, Hacia JG, Bromage TG, Boyde A, Lei Y, Xu Y, Miller JD, Paine ML, Snead ML. The circadian clock modulates enamel development. J Biol Rhythms 2012;27(3):237-45.
469. Canham LT, Reeves CL, LoniA, Houlton MR, Newey JP, Simons AJ, Cox TI. Calcium phosphate nucleation on porous silicon: factors influencing kinetics in acellular simulated body fluids. Thin Solid Films 1997;297:304-7.
470. Kokubo T, Takadama H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 2006;27:2907-15.
471. Uskoković V. Composites comprising cholesterol and carboxymethyl cellulose. Coll Surf B: Biointerfaces 2008;61:250-61.
472. Bunker C. E, Harruff BA, Pathak P, Payzant A, Allard LF, Sun YP. Formation of cadmium sulfide nanoparticles in reverse micelles: extreme sensitivity to preparation procedure. Langmuir 2004;20:5642-4.
473. Hou WT, Feng QL. Morphologies and growth model of biomimetic fabricated calcite crystals using amino acids and insoluble matrix membranes of Mytilus edulis. Crystal Growth Design 2006;6: 1086-90.
474. Li D, Kaner RB. Shape and aggregation control of nanoparticles: not shaken, not stirred. J Am Chem Soc 2006;128:968-75.
475. Perumal S, Ramadass SL, Badhan M. Sol-gel processed mupirocin silica microspheres loaded in collagen scaffold: a synergistic bio-composite for wound healing. Eur J Pharm Sci 2014;52:26-33.
476. Uskoković V. Entering the era of nanoscience: time to be so small. J Biomed Nanotech 2013;9: 1441-70.
477. Fan Q, Wang YE, Zhao X, Loo JS, Zuo YY. Adverse biophysical effects of hydroxyapatite nanoparticles on natural pulmonary surfactant. ACS Nano 2011;5(8):6410-6.
478. Wainwright SA, Biggs WD, Currey JD, Gosline JM. The mechanical design of organisms. London: Edward Arnold; 1976.
479. Perry CC. Biomaterials. In: Interrante LV, Hampden-Smith MJ, editors. Chemistry of advanced materials: an overview, New York: Wiley-VCH; 1998, p. 499 - 562.
480. Gai Z, Kalinin SV, Li AP, Shen J, Baddorf AP. In situ observations and tuning of physical and chemical phenomena on the surfaces of strongly correlated oxides. Adv Funct Mat 2013;23:2477-89.
481. Zhang L, Jeon Y, Shim H, Lee G. Direct observation of hopping and merging of single Au adatoms to form dimers on Si(111)-(7 × 7). J Vac Sci Technol A 2012;30:061406.
482. Fuchigami K, Gai Z, Ward TZ, Yin LF, Snijders PC, Plummer EW, Shen J. Tunable metallicity of the La5/8Ca3/8MnO3 (001) surface by an oxygen overlayer. Phys Rev Lett 2009;102:066104.
483. Vasudevan RK, Bogle KA, Kumar A, Jesse S, Magaraggia R, Stamps R, Ogale SB, Potdar HS, Nagarajan V. Ferroelectric and electrical characterization of multiferroic BiFeO3 at the single nanoparticle level. Appl Phys Lett 2011;99:252905.
484. Kim YM, He J, Biegalski MD, Ambaye H, Lauter V, Christen HM, Pantelides ST, Pennycook SJ, Kalinin SV, Borisevich AY. Probing oxygen vacancy concentration and homogeneity in solid-oxide fuel-cell cathode materials on the subunit-cell level. Nature Materials 2012;11:888-94.